Big Bull的个人主页 - 老虎社区

Big Bull

Big Bull

暂无个人介绍

IP属地：未知

108关注

12粉丝

0主题

0勋章

2021-12-16

Okay 👌

抱歉，原内容已删除

2021-12-05

Ok

Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock

2021-11-24

👌

Musk Has Now Sold More Than Half the Stock He Vowed on Twitter

2021-11-24

Good

Musk Has Now Sold More Than Half the Stock He Vowed on Twitter

2021-11-23

👌

Lucid Motors Is Set Up To Surpass Tesla

2021-11-23

Okay 👌

抱歉，原内容已删除

2021-11-22

👍

Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development

2021-11-22

Okay

抱歉，原内容已删除

2021-11-19

Is time to fly up to the moon Ali! [看涨]

@捷克Jack:财报季专供：中概风险，从权利金里赚回来吧

2021-11-18

Okay

抱歉，原内容已删除

2021-11-18

Good

Cassava Sciences Stock Tumbles on News of SEC Investigation

2021-11-18

Okay

Elon Musk has sold more Tesla shares than he needs to pay current tax bill

2021-11-10

Okay 👌

Tesla Further Extends Delivery Time For Model Y Standard Range In China

2021-11-03

👌

KFC Wanted to ‘Beat Us Down,’ Pilgrim’s Pride Witness Says

2021-11-03

Okay

抱歉，原内容已删除

2021-11-01

Okay

2 Growth Stocks That Could Deliver 1,000% Returns

2021-11-01

👍

Federal Reserve decision, October jobs report: What to know this week

2021-10-30

Up Tesla

抱歉，原内容已删除

去老虎APP查看更多动态

{"i18n":{"language":"zh_CN"},"userPageInfo":{"id":4094912318336650,"uuid":"4094912318336650","gmtCreate":1631809253633,"gmtModify":1635129709650,"name":"Big Bull","pinyin":"bigbullbigbull","introduction":"","introductionEn":"","signature":"","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":12,"headSize":108,"tweetSize":18,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":1,"name":"萌萌虎","nameTw":"萌萌虎","represent":"呱呱坠地","factor":"评论帖子3次或发布1条主帖（非转发）","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":null,"userBadges":[{"badgeId":"e50ce593bb40487ebfb542ca54f6a561-1","templateUuid":"e50ce593bb40487ebfb542ca54f6a561","name":"出道虎友","description":"加入老虎社区500天","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.02.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"976c19eed35f4cd78f17501c2e99ef37-1","templateUuid":"976c19eed35f4cd78f17501c2e99ef37","name":"博闻投资者","description":"累计交易超过10只正股","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"228c86a078844d74991fff2b7ab2428d-2","templateUuid":"228c86a078844d74991fff2b7ab2428d","name":"投资总监虎","description":"证券账户累计交易金额达到30万美元","bigImgUrl":"https://static.tigerbbs.com/9d20b23f1b6335407f882bc5c2ad12c0","smallImgUrl":"https://static.tigerbbs.com/ada3b4533518ace8404a3f6dd192bd29","grayImgUrl":"https://static.tigerbbs.com/177f283ba21d1c077054dac07f88f3bd","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.32%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"518b5610c3e8410da5cfad115e4b0f5a-1","templateUuid":"518b5610c3e8410da5cfad115e4b0f5a","name":"实盘交易者","description":"完成一笔实盘交易","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"35ec162348d5460f88c959321e554969-2","templateUuid":"35ec162348d5460f88c959321e554969","name":"宗师交易员","description":"证券或期货账户累计交易次数达到100次","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.28","exceedPercentage":"80.07%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":"未知","starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":690874632,"gmtCreate":1639659855187,"gmtModify":1639659855348,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay 👌&nbsp;","listText":"Okay 👌&nbsp;","text":"Okay 👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690874632","repostId":"1142996286","repostType":4,"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608178636,"gmtCreate":1638672598165,"gmtModify":1638672598165,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608178636","repostId":"2188057871","repostType":4,"repost":{"id":"2188057871","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638580800,"share":"https://www.laohu8.com/m/news/2188057871?lang=&edition=full","pubTime":"2021-12-04 09:20","market":"us","language":"en","title":"Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2188057871","media":"Dow Jones","summary":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic bo","content":"<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 09:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4527":"明星科技股","BK4567":"ESG概念","ADBE":"Adobe","BK4534":"瑞士信贷持仓","BK4528":"SaaS概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4566":"资本集团","DOCU":"Docusign"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188057871","content_text":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic boom was slowing down\nShares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.\nDocuSign $(DOCU)$ Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.\nSome of that investor fear seemed to transfer over to Adobe $(ADBE)$, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.\nThe decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"\n\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.\nAdobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"\nWhile other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.\nAdobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.\nShares of Adobe were up 86% since March 2020 as of Thursday's close.","news_type":1},"isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874953784,"gmtCreate":1637722659359,"gmtModify":1637722659423,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874953784","repostId":"1178572049","repostType":4,"repost":{"id":"1178572049","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637721621,"share":"https://www.laohu8.com/m/news/1178572049?lang=&edition=full","pubTime":"2021-11-24 10:40","market":"us","language":"en","title":"Musk Has Now Sold More Than Half the Stock He Vowed on Twitter","url":"https://stock-news.laohu8.com/highlight/detail?id=1178572049","media":"Tiger Newspress","summary":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfwa","content":"<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Has Now Sold More Than Half the Stock He Vowed on Twitter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Has Now Sold More Than Half the Stock He Vowed on Twitter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-24 10:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178572049","content_text":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.\nThe billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.\nWith the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.\n\nTo reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.\nMusk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.\nMusk, 50, is the world’s richest person with a $303.7 billion fortune, according to the Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874925356,"gmtCreate":1637722096502,"gmtModify":1637722118342,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874925356","repostId":"1178572049","repostType":2,"repost":{"id":"1178572049","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637721621,"share":"https://www.laohu8.com/m/news/1178572049?lang=&edition=full","pubTime":"2021-11-24 10:40","market":"us","language":"en","title":"Musk Has Now Sold More Than Half the Stock He Vowed on Twitter","url":"https://stock-news.laohu8.com/highlight/detail?id=1178572049","media":"Tiger Newspress","summary":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfwa","content":"<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Has Now Sold More Than Half the Stock He Vowed on Twitter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Has Now Sold More Than Half the Stock He Vowed on Twitter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-24 10:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178572049","content_text":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.\nThe billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.\nWith the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.\n\nTo reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.\nMusk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.\nMusk, 50, is the world’s richest person with a $303.7 billion fortune, according to the Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875223948,"gmtCreate":1637659536449,"gmtModify":1637659536541,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875223948","repostId":"1170981862","repostType":4,"repost":{"id":"1170981862","pubTimestamp":1637656549,"share":"https://www.laohu8.com/m/news/1170981862?lang=&edition=full","pubTime":"2021-11-23 16:35","market":"us","language":"en","title":"Lucid Motors Is Set Up To Surpass Tesla","url":"https://stock-news.laohu8.com/highlight/detail?id=1170981862","media":"seekingalpha","summary":"First-movers are often assumed to carry a lasting advantage. This is not the case and, especially with the EV market, the first-mover advantage is not a powerful long-term asset.Tesla’s success has made Lucid’s challenge far more effective than it otherwise would’ve been, creating a market for the car and the investor interest required to fund the company.Lucid looks to be a far more nimble company than Tesla, allowing it to take the industry’s rapid evolution in stride, with a superior vehicle ","content":"<p>Summary</p>\n<ul>\n <li>First-movers are often assumed to carry a lasting advantage. This is not the case and, especially with the EV market, the first-mover advantage is not a powerful long-term asset.</li>\n <li>Tesla’s success has made Lucid’s challenge far more effective than it otherwise would’ve been, creating a market for the car and the investor interest required to fund the company.</li>\n <li>Lucid looks to be a far more nimble company than Tesla, allowing it to take the industry’s rapid evolution in stride, with a superior vehicle platform.</li>\n</ul>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/876e502aba19c09f0db1a83835e9bcd9\" tg-width=\"768\" tg-height=\"512\" referrerpolicy=\"no-referrer\"><span>Spencer Platt/Getty Images News</span></p>\n<p>Lucid Motors (LCID) only recently began delivering its first vehicles to customers, yet it has&nbsp;already received&nbsp;the laurels of MotorTrend’s 2022 Car of the Year. The vehicle’sindustry-leading drivetrain technology, great design, and solid build quality earned it that title. Yet, Tesla (TSLA) remains the king of the EV. Of course, one car with limited volume isn’t going to change anything, though that’s not the way things are set to stay.I wrote on Lucid’s growth prospects&nbsp;some time ago, so that’s not the focus of today’s article. Instead, I’m here to discuss why Lucid Motors is well-positioned to surpass Tesla due to a rapidly eroding first-mover advantage. In&nbsp;an article on TeslaI published earlier this year, I discussed how the brand’s cache is already starting to slip. While we can sit here and debate that General Motors (GM) was actually the first EV manufacturer with its EV1 back in the ’90s, I think we all know that Tesla really earned that title. This article will discuss why that may not be such a good thing.</p>\n<p>The First-Mover Fallacy</p>\n<p>Oftentimes, the first-mover in a major new market is identified as said market’s future leader. It’s easy to see why, as they’re often associated with the market that they’ve created. Yet, think web browser and you probably think of Alphabet’s (GOOG) Google Chrome. Think of email, you’re again most likely going to think of a Google product -- this time Gmail. Social media? Facebook (FB). Cell phone? iPhone. You get the idea. What’s one thing all of these different products have in common? None of them were the first to market. Yet, despite this, they’ve all become the pinnacle of each of their respective markets.</p>\n<p>So, the big question is “Why?” Why are none of these transformative first-movers the leaders of their industry? Well, there’s not really one blanket answer.A 2005 publication&nbsp;to The Harvard Business Review discusses the idea of this fallacy.</p>\n<blockquote>\n “But for every academic study proving that first-mover advantages exist, there is a study proving they do not. While some well-known first-movers, such as Gillette in safety razors and Sony in personal stereos, have enjoyed considerable success, others, such as Xerox in fax machines and eToys in Internet retailing, have failed. We have found that the differences in outcome are not random—that first-mover status can confer advantages, but it does not do so categorically. Much depends on the circumstances in which it is sought.”\n</blockquote>\n<p>I find this last sentence to be particularly powerful, as every industry is vastly different and allows for alternate outcomes. There will always be some level of unpredictability, dumb luck if you will, though The Harvard Business Review identified two factors that seem to reliably indicate whether or not the first-mover advantage will last. “The pace at which the technology of the product in question is evolving and the pace at which the market for that product is expanding” are these two critical factors.</p>\n<p>The rate of innovation in the EV sector is currently one of the most impressive global efforts I’ve ever seen, as is the rate at which the market is expanding.Since 2015, global sales of EVs have grown at an average rate of 50%. Yet, this is heating up. Global EV sales in 2021are expected&nbsp;to rise 83% over last year, increasing the rate of adoption as more options flood the market. In order for first-movers to be successful, there needs to be substantial interest in the market. This plays into Tesla’s hands. However, the extreme level of growth in the market necessitates more competition. This opens the door for others to combat Tesla.</p>\n<p>Let’s come back to the idea of rapid innovation as well. Companies likeNano One(OTCPK:NNOMF) andSES(IVAN), both of which I’ve covered, are looking to introduce industry-shifting innovations. They’re not alone either. CATL, a Chinese battery producer, is&nbsp;on the verge&nbsp;of becoming the country’s second-largest company. CATL&nbsp;is on pace&nbsp;to spend nearly $1 billion on R&amp;D this year, up 115% over the first half of last year. In this market of rapid innovation, it is nigh on impossible for any one company to stay at the forefront.</p>\n<p>The EV industry has failed what The Harvard Business review deemed the two most important litmus tests in determining whether a first-mover truly has any advantage. Not great news for the incumbent leader, Tesla. Though, I argue that there is more that can bring down the power of a first-mover. Complacency can create opportunities for others to thrive. In the next section, I will discuss how Tesla’s complacency, as well as a few other factors, mean that there are more reasons than a highly innovative and quickly-growing market for Tesla to fall.</p>\n<p>Where Tesla’s Faltering</p>\n<p>I think that there’s no question Lucid owes a majority of its early success to Tesla. Tesla essentially created the market for Lucid and, maybe even more importantly, got investors to pay attention to them. All of that attention&nbsp;allowed Lucid Motors&nbsp;to raise $4.4 billion in its SPAC merger with Churchill Capital. That money was enough for Lucid to bring the Air to market, continue development work on its SUV, and expand its production footprint. That’s something that Tesla never had and will be immensely powerful for Lucid Motors. Now, I’m not saying that Lucid has an easy road to mass production, far from it, but there’s no question that it’s easier than Tesla’s was. This is the first stage in which Lucid is benefiting from Tesla’s prior struggles.</p>\n<p>Though, a good start means nothing if the company can’t build on it. This is where I believe that Tesla is simply holding the door open for Lucid Motors. Tesla has seemingly become lazy and no longer has that fire to continue innovating. I can’t say I blame them, they’ve got several years on their closest competition and their cars are some of the best in the category. Well, perhaps before the Air came to market.</p>\n<p>The quality control issues&nbsp;that plagued Tesla&nbsp;in its early days were an issue, though forgivable given the company’s tumultuous path to production. Yet, there are still&nbsp;a number of reports&nbsp;concerning poor build quality. These issues&nbsp;are even present&nbsp;on the company’s $130,000 Model S Plaid. At this point, these issues are inexcusable. Especially on a $130,000 car. Lucid&nbsp;has worked hard&nbsp;to make sure it avoided making the same mistakes, even delaying initial production to do so, and&nbsp;it’s paid off. We’ll have to wait and see if a larger sample size produces the same result but, so far, the quality of the Air looks to be on par with its luxury price tag.</p>\n<p>The other major area that Tesla seems to be lacking in is powertrain development. Having just released a car that goes 0-60 in less than two seconds, this may seem like a bit of an unjustified claim. But that’s not the only way to measure the capability of a powertrain. In&nbsp;an older article, I reviewed the quality of Lucid’s core product offering. That article focused on its powertrain efficiency. The Air is capable of&nbsp;up to 520 miles of range, at an efficiency of 4.64 miles/kWh (the electric equivalent to miles/gallon). Granted, this is for the company’s Grand Touring trim,which costs a whopping $139,000. The base version of the Air, which costs $77,400, has an efficiency of 5.41 miles/kWh, traveling 406 miles on a single charge (using an estimated battery size of75 kWh). Tesla’s Long Range Model S, which travels412 miles&nbsp;on a single charge, is Tesla’s most efficient vehicle with an efficiency of 4.12 miles/kWh. I’m not going to get into the specifics on how this was achieved, as this was all explained in&nbsp;that previous article. For our purposes here, it’s just important to understand that it&nbsp;<i>was</i>&nbsp;done.</p>\n<p>Now, it’s easy to point to Tesla’s batteries and say that they’re the most advanced in the world. I wouldn’t argue with you there, though I’m not sure that’ll be the case for very long. It’s already becoming far less obvious than it once was, as improvements become increasingly more iterative and less significant. Essentially, Tesla’s stuck making small incremental changes while its competitors, which once were far behind, have had the chance to catch up. The company hopes that its new 4680 cells will give it the next big leap, but I think they’re moving in the wrong direction. Below is a visual representation, a top-down view of what a Tesla battery pack looks like.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/dfb24c19eee013cc09407af804bcfc65\" tg-width=\"757\" tg-height=\"521\" referrerpolicy=\"no-referrer\"><span>Source: Author’s Creation</span></p>\n<p>All of the red space you see is wasted space. Trying to fit a bunch of cylinders in a rectangular container is always going to be inefficient. Hence, from a volumetric density perspective, the prismatic cell architecture is superior. In vehicles, where space is a premium, volumetric density is a critical performance benchmark. Though, I think that this speaks to a larger issue in Tesla’s battery cell development. Ina previous article, I discussed how Tesla’s batteries are becoming a liability. The company’s unwillingness to consider lithium metal batteries as the next generation of lithium-ion batteries could see the company’s battery advantage completely erode by the end of the decade.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/d9f51e943a3340831639c2db1513cc4a\" tg-width=\"1280\" tg-height=\"486\" referrerpolicy=\"no-referrer\"><span>Source:C&amp;EN</span></p>\n<p>The fact that Lucid isn’t reliant upon their own battery technology means that it is far more nimble during this time of significant battery iteration. As noted in the above section, the EV industry is likely to be driven by a series of disruptive technologies through the foreseeable future, and a company that is easily able to consistently pivot to these disruptive technologies has a better chance of staying on top of the market. To give Tesla credit, its cells are some of the best on the market. However, it’s hard to stay at the top of two different fields, car design and battery design, and the desire to do so often results in failure. The fact that Lucid walloped Tesla in drivetrain efficiency speaks to the fact that Tesla is no longer engineering the best electric vehicles and all signs point to Tesla’s battery advantage dwindling.</p>\n<p>Investor Takeaway</p>\n<p>Look, I don’t think that Tesla, or Lucid Motors for that matter, should be valued close to where they are today but the fact of the matter is that they are. If Lucid will ultimately be the stronger of the two, take that as you will. I won’t pretend that I can predict the flow of the market with companies like Tesla and Lucid, which trade so far removed from any fundamentals, but I do think that time will prove that Lucid is the better of the two companies.</p>\n<p>Ignoring share prices, Lucid Motors is gearing up for some pretty extreme growth. The company has a lot of cash on hand and is using it to invest in growing its production and product offerings. Similar to Tesla, Lucid plans to introduce mass-market vehicles after its niche offerings begin generating capital and brand awareness. As the disclosure below notes, I own shares of Lucid Motors. This may seem strange, as I just said that their fundamentals don’t come close to justifying their valuation. Though, when shares were under $20, it was far more appealing. To be completely honest, at this stage, I’m just holding to see where it goes.</p>","source":"seekingalpha","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Lucid Motors Is Set Up To Surpass Tesla</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLucid Motors Is Set Up To Surpass Tesla\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-23 16:35 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/article/4471273-lucid-motors-lcid-stock-surpass-tesla><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Summary\n\nFirst-movers are often assumed to carry a lasting advantage. This is not the case and, especially with the EV market, the first-mover advantage is not a powerful long-term asset.\nTesla’s ...</p>\n\n<a href=\"https://seekingalpha.com/article/4471273-lucid-motors-lcid-stock-surpass-tesla\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉","LCID":"Lucid Group Inc"},"source_url":"https://seekingalpha.com/article/4471273-lucid-motors-lcid-stock-surpass-tesla","is_english":true,"share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","article_id":"1170981862","content_text":"Summary\n\nFirst-movers are often assumed to carry a lasting advantage. This is not the case and, especially with the EV market, the first-mover advantage is not a powerful long-term asset.\nTesla’s success has made Lucid’s challenge far more effective than it otherwise would’ve been, creating a market for the car and the investor interest required to fund the company.\nLucid looks to be a far more nimble company than Tesla, allowing it to take the industry’s rapid evolution in stride, with a superior vehicle platform.\n\nSpencer Platt/Getty Images News\nLucid Motors (LCID) only recently began delivering its first vehicles to customers, yet it has already received the laurels of MotorTrend’s 2022 Car of the Year. The vehicle’sindustry-leading drivetrain technology, great design, and solid build quality earned it that title. Yet, Tesla (TSLA) remains the king of the EV. Of course, one car with limited volume isn’t going to change anything, though that’s not the way things are set to stay.I wrote on Lucid’s growth prospects some time ago, so that’s not the focus of today’s article. Instead, I’m here to discuss why Lucid Motors is well-positioned to surpass Tesla due to a rapidly eroding first-mover advantage. In an article on TeslaI published earlier this year, I discussed how the brand’s cache is already starting to slip. While we can sit here and debate that General Motors (GM) was actually the first EV manufacturer with its EV1 back in the ’90s, I think we all know that Tesla really earned that title. This article will discuss why that may not be such a good thing.\nThe First-Mover Fallacy\nOftentimes, the first-mover in a major new market is identified as said market’s future leader. It’s easy to see why, as they’re often associated with the market that they’ve created. Yet, think web browser and you probably think of Alphabet’s (GOOG) Google Chrome. Think of email, you’re again most likely going to think of a Google product -- this time Gmail. Social media? Facebook (FB). Cell phone? iPhone. You get the idea. What’s one thing all of these different products have in common? None of them were the first to market. Yet, despite this, they’ve all become the pinnacle of each of their respective markets.\nSo, the big question is “Why?” Why are none of these transformative first-movers the leaders of their industry? Well, there’s not really one blanket answer.A 2005 publication to The Harvard Business Review discusses the idea of this fallacy.\n\n “But for every academic study proving that first-mover advantages exist, there is a study proving they do not. While some well-known first-movers, such as Gillette in safety razors and Sony in personal stereos, have enjoyed considerable success, others, such as Xerox in fax machines and eToys in Internet retailing, have failed. We have found that the differences in outcome are not random—that first-mover status can confer advantages, but it does not do so categorically. Much depends on the circumstances in which it is sought.”\n\nI find this last sentence to be particularly powerful, as every industry is vastly different and allows for alternate outcomes. There will always be some level of unpredictability, dumb luck if you will, though The Harvard Business Review identified two factors that seem to reliably indicate whether or not the first-mover advantage will last. “The pace at which the technology of the product in question is evolving and the pace at which the market for that product is expanding” are these two critical factors.\nThe rate of innovation in the EV sector is currently one of the most impressive global efforts I’ve ever seen, as is the rate at which the market is expanding.Since 2015, global sales of EVs have grown at an average rate of 50%. Yet, this is heating up. Global EV sales in 2021are expected to rise 83% over last year, increasing the rate of adoption as more options flood the market. In order for first-movers to be successful, there needs to be substantial interest in the market. This plays into Tesla’s hands. However, the extreme level of growth in the market necessitates more competition. This opens the door for others to combat Tesla.\nLet’s come back to the idea of rapid innovation as well. Companies likeNano One(OTCPK:NNOMF) andSES(IVAN), both of which I’ve covered, are looking to introduce industry-shifting innovations. They’re not alone either. CATL, a Chinese battery producer, is on the verge of becoming the country’s second-largest company. CATL is on pace to spend nearly $1 billion on R&D this year, up 115% over the first half of last year. In this market of rapid innovation, it is nigh on impossible for any one company to stay at the forefront.\nThe EV industry has failed what The Harvard Business review deemed the two most important litmus tests in determining whether a first-mover truly has any advantage. Not great news for the incumbent leader, Tesla. Though, I argue that there is more that can bring down the power of a first-mover. Complacency can create opportunities for others to thrive. In the next section, I will discuss how Tesla’s complacency, as well as a few other factors, mean that there are more reasons than a highly innovative and quickly-growing market for Tesla to fall.\nWhere Tesla’s Faltering\nI think that there’s no question Lucid owes a majority of its early success to Tesla. Tesla essentially created the market for Lucid and, maybe even more importantly, got investors to pay attention to them. All of that attention allowed Lucid Motors to raise $4.4 billion in its SPAC merger with Churchill Capital. That money was enough for Lucid to bring the Air to market, continue development work on its SUV, and expand its production footprint. That’s something that Tesla never had and will be immensely powerful for Lucid Motors. Now, I’m not saying that Lucid has an easy road to mass production, far from it, but there’s no question that it’s easier than Tesla’s was. This is the first stage in which Lucid is benefiting from Tesla’s prior struggles.\nThough, a good start means nothing if the company can’t build on it. This is where I believe that Tesla is simply holding the door open for Lucid Motors. Tesla has seemingly become lazy and no longer has that fire to continue innovating. I can’t say I blame them, they’ve got several years on their closest competition and their cars are some of the best in the category. Well, perhaps before the Air came to market.\nThe quality control issues that plagued Tesla in its early days were an issue, though forgivable given the company’s tumultuous path to production. Yet, there are still a number of reports concerning poor build quality. These issues are even present on the company’s $130,000 Model S Plaid. At this point, these issues are inexcusable. Especially on a $130,000 car. Lucid has worked hard to make sure it avoided making the same mistakes, even delaying initial production to do so, and it’s paid off. We’ll have to wait and see if a larger sample size produces the same result but, so far, the quality of the Air looks to be on par with its luxury price tag.\nThe other major area that Tesla seems to be lacking in is powertrain development. Having just released a car that goes 0-60 in less than two seconds, this may seem like a bit of an unjustified claim. But that’s not the only way to measure the capability of a powertrain. In an older article, I reviewed the quality of Lucid’s core product offering. That article focused on its powertrain efficiency. The Air is capable of up to 520 miles of range, at an efficiency of 4.64 miles/kWh (the electric equivalent to miles/gallon). Granted, this is for the company’s Grand Touring trim,which costs a whopping $139,000. The base version of the Air, which costs $77,400, has an efficiency of 5.41 miles/kWh, traveling 406 miles on a single charge (using an estimated battery size of75 kWh). Tesla’s Long Range Model S, which travels412 miles on a single charge, is Tesla’s most efficient vehicle with an efficiency of 4.12 miles/kWh. I’m not going to get into the specifics on how this was achieved, as this was all explained in that previous article. For our purposes here, it’s just important to understand that it was done.\nNow, it’s easy to point to Tesla’s batteries and say that they’re the most advanced in the world. I wouldn’t argue with you there, though I’m not sure that’ll be the case for very long. It’s already becoming far less obvious than it once was, as improvements become increasingly more iterative and less significant. Essentially, Tesla’s stuck making small incremental changes while its competitors, which once were far behind, have had the chance to catch up. The company hopes that its new 4680 cells will give it the next big leap, but I think they’re moving in the wrong direction. Below is a visual representation, a top-down view of what a Tesla battery pack looks like.\nSource: Author’s Creation\nAll of the red space you see is wasted space. Trying to fit a bunch of cylinders in a rectangular container is always going to be inefficient. Hence, from a volumetric density perspective, the prismatic cell architecture is superior. In vehicles, where space is a premium, volumetric density is a critical performance benchmark. Though, I think that this speaks to a larger issue in Tesla’s battery cell development. Ina previous article, I discussed how Tesla’s batteries are becoming a liability. The company’s unwillingness to consider lithium metal batteries as the next generation of lithium-ion batteries could see the company’s battery advantage completely erode by the end of the decade.\nSource:C&EN\nThe fact that Lucid isn’t reliant upon their own battery technology means that it is far more nimble during this time of significant battery iteration. As noted in the above section, the EV industry is likely to be driven by a series of disruptive technologies through the foreseeable future, and a company that is easily able to consistently pivot to these disruptive technologies has a better chance of staying on top of the market. To give Tesla credit, its cells are some of the best on the market. However, it’s hard to stay at the top of two different fields, car design and battery design, and the desire to do so often results in failure. The fact that Lucid walloped Tesla in drivetrain efficiency speaks to the fact that Tesla is no longer engineering the best electric vehicles and all signs point to Tesla’s battery advantage dwindling.\nInvestor Takeaway\nLook, I don’t think that Tesla, or Lucid Motors for that matter, should be valued close to where they are today but the fact of the matter is that they are. If Lucid will ultimately be the stronger of the two, take that as you will. I won’t pretend that I can predict the flow of the market with companies like Tesla and Lucid, which trade so far removed from any fundamentals, but I do think that time will prove that Lucid is the better of the two companies.\nIgnoring share prices, Lucid Motors is gearing up for some pretty extreme growth. The company has a lot of cash on hand and is using it to invest in growing its production and product offerings. Similar to Tesla, Lucid plans to introduce mass-market vehicles after its niche offerings begin generating capital and brand awareness. As the disclosure below notes, I own shares of Lucid Motors. This may seem strange, as I just said that their fundamentals don’t come close to justifying their valuation. Though, when shares were under $20, it was far more appealing. To be completely honest, at this stage, I’m just holding to see where it goes.","news_type":1},"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875229796,"gmtCreate":1637659508214,"gmtModify":1637659508214,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay 👌&nbsp;","listText":"Okay 👌&nbsp;","text":"Okay 👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875229796","repostId":"2185638587","repostType":4,"isVote":1,"tweetType":1,"viewCount":577,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872777574,"gmtCreate":1637582901485,"gmtModify":1637582901485,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872777574","repostId":"1171692239","repostType":4,"repost":{"id":"1171692239","pubTimestamp":1637582731,"share":"https://www.laohu8.com/m/news/1171692239?lang=&edition=full","pubTime":"2021-11-22 20:05","market":"us","language":"en","title":"Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development","url":"https://stock-news.laohu8.com/highlight/detail?id=1171692239","media":"Reuters","summary":"BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its ","content":"<p>BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.</p>\n<p>Sanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more</p>\n<p>Sanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.</p>\n<p>The French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.</p>\n<p>Baidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.</p>\n<p>\"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.</p>\n<p>An mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.</p>\n<p>Baidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.</p>\n<p>Specifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to&nbsp;lab studies and animal tests, which haven't gone through peer-review.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-22 20:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and ...</p>\n\n<a href=\"https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNYNF":"Sanofi","BIDU":"百度","09888":"百度集团-SW"},"source_url":"https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171692239","content_text":"BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.\nSanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more\nSanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.\nThe French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.\nBaidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.\n\"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.\nAn mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.\nBaidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.\nSpecifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to lab studies and animal tests, which haven't gone through peer-review.","news_type":1},"isVote":1,"tweetType":1,"viewCount":631,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872777162,"gmtCreate":1637582785582,"gmtModify":1637582785582,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872777162","repostId":"1156227996","repostType":4,"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876204588,"gmtCreate":1637314320200,"gmtModify":1637314320356,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Is time to fly up to the moon Ali!&nbsp;[看涨]&nbsp;","listText":"Is time to fly up to the moon Ali!&nbsp;[看涨]&nbsp;","text":"Is time to fly up to the moon Ali! [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876204588","repostId":"876205840","repostType":1,"repost":{"id":876205840,"gmtCreate":1637314097576,"gmtModify":1637378903861,"author":{"id":"212008496769156","authorId":"212008496769156","name":"捷克Jack","avatar":"https://static.tigerbbs.com/7cc48e563d37c21562541a2874ce20e4","crmLevel":3,"crmLevelSwitch":0},"themes":[],"title":"财报季专供：中概风险，从权利金里赚回来吧","htmlText":"今天的主角是<a target=\"_blank\" href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 财报后大跌11%，可能还要跌。 原因很简单： 收入不及预期 利润不及预期 指引还下调了 唯一还不错的是云业务的发展不错以及海外活跃用户的增长。但中国人往往喜欢“丑话说在前面”，当这一季表现得这么糟糕的时候，往往就有可能是为了以后在做铺垫，因此很多人也在考虑要不要抄底。 财报季我做了很多“财报前期权策略”，本质上还是在意财报这种公司事件带来的波动性。的确，很多人谈“波动色变”，但是我觉得，波动也同时给我们带啦机会。 对期权玩家来说，波动——Volatility是最重要的数据指标之一。简单地说，当波动率越大的时候，相同情况产生的权利金就越高，这样对期权的概念而 今天的策略很简单，naked&nbsp;sell&nbsp;put 可能很多朋友都用惯了这个策略，我想再强调一些概念。 首先，Long和Short，分别代表“多方”和“空方”，代表你是看涨还是看跌。 然后，Buy和Sell，分别代表“买”和“卖”的动作，代表你对标的产品的交易动作。 那么，有Buy操作的一定是“多方”，有Sell操作的一定是“空方”对吗？ 显然不是。 因为期权分为“看涨期权Call”和“看跌期权Put”—— 当我们“Buy&nbsp;Put”，也就买入看跌期权的时候，我们就是“Short空方”，和我们“Sell&nbsp;Call”也就是卖出看涨期权的时候一样，都是“Short空方”； 反之，当我们“Buy&nbsp;Call”买入看涨期权的时候，我们就是“Long多方”，和我们“Sell&amp;nb","listText":"今天的主角是<a target=\"_blank\" href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 财报后大跌11%，可能还要跌。 原因很简单： 收入不及预期 利润不及预期 指引还下调了 唯一还不错的是云业务的发展不错以及海外活跃用户的增长。但中国人往往喜欢“丑话说在前面”，当这一季表现得这么糟糕的时候，往往就有可能是为了以后在做铺垫，因此很多人也在考虑要不要抄底。 财报季我做了很多“财报前期权策略”，本质上还是在意财报这种公司事件带来的波动性。的确，很多人谈“波动色变”，但是我觉得，波动也同时给我们带啦机会。 对期权玩家来说，波动——Volatility是最重要的数据指标之一。简单地说，当波动率越大的时候，相同情况产生的权利金就越高，这样对期权的概念而 今天的策略很简单，naked&nbsp;sell&nbsp;put 可能很多朋友都用惯了这个策略，我想再强调一些概念。 首先，Long和Short，分别代表“多方”和“空方”，代表你是看涨还是看跌。 然后，Buy和Sell，分别代表“买”和“卖”的动作，代表你对标的产品的交易动作。 那么，有Buy操作的一定是“多方”，有Sell操作的一定是“空方”对吗？ 显然不是。 因为期权分为“看涨期权Call”和“看跌期权Put”—— 当我们“Buy&nbsp;Put”，也就买入看跌期权的时候，我们就是“Short空方”，和我们“Sell&nbsp;Call”也就是卖出看涨期权的时候一样，都是“Short空方”； 反之，当我们“Buy&nbsp;Call”买入看涨期权的时候，我们就是“Long多方”，和我们“Sell&amp;nb","text":"今天的主角是$阿里巴巴(BABA)$ $阿里巴巴-SW(09988)$ 财报后大跌11%，可能还要跌。 原因很简单： 收入不及预期 利润不及预期 指引还下调了 唯一还不错的是云业务的发展不错以及海外活跃用户的增长。但中国人往往喜欢“丑话说在前面”，当这一季表现得这么糟糕的时候，往往就有可能是为了以后在做铺垫，因此很多人也在考虑要不要抄底。 财报季我做了很多“财报前期权策略”，本质上还是在意财报这种公司事件带来的波动性。的确，很多人谈“波动色变”，但是我觉得，波动也同时给我们带啦机会。 对期权玩家来说，波动——Volatility是最重要的数据指标之一。简单地说，当波动率越大的时候，相同情况产生的权利金就越高，这样对期权的概念而 今天的策略很简单，naked sell put 可能很多朋友都用惯了这个策略，我想再强调一些概念。 首先，Long和Short，分别代表“多方”和“空方”，代表你是看涨还是看跌。 然后，Buy和Sell，分别代表“买”和“卖”的动作，代表你对标的产品的交易动作。 那么，有Buy操作的一定是“多方”，有Sell操作的一定是“空方”对吗？ 显然不是。 因为期权分为“看涨期权Call”和“看跌期权Put”—— 当我们“Buy Put”，也就买入看跌期权的时候，我们就是“Short空方”，和我们“Sell Call”也就是卖出看涨期权的时候一样，都是“Short空方”； 反之，当我们“Buy Call”买入看涨期权的时候，我们就是“Long多方”，和我们“Sell&nb","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876205840","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":462,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878532818,"gmtCreate":1637204855941,"gmtModify":1637204855941,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878532818","repostId":"1163438397","repostType":4,"isVote":1,"tweetType":1,"viewCount":633,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878532155,"gmtCreate":1637204802922,"gmtModify":1637204802922,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878532155","repostId":"1161909759","repostType":4,"repost":{"id":"1161909759","pubTimestamp":1637203262,"share":"https://www.laohu8.com/m/news/1161909759?lang=&edition=full","pubTime":"2021-11-18 10:41","market":"us","language":"en","title":"Cassava Sciences Stock Tumbles on News of SEC Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=1161909759","media":"The Street","summary":"The biotech faces claims of manipulating research results of its Alzheimer’s drug.\n$Cassava Sciences","content":"<p>The biotech faces claims of manipulating research results of its Alzheimer’s drug.</p>\n<p>$Cassava Sciences&nbsp;(<b>SAVA</b>)$&nbsp;plummeted Wednesday after disclosing that \"certain government agencies\", which reportedly included&nbsp;the Securities and Exchange Commission, were investing claims the biotech&nbsp;manipulated research results of its experimental Alzheimer’s drug,&nbsp;simufilam.</p>\n<p>Shares of the Austin, Texas company were&nbsp;down more&nbsp;than 23% to $47.07&nbsp;Wednesday.</p>\n<p><img src=\"https://static.tigerbbs.com/ba12f81714da2c89bed996a8439c131d\" tg-width=\"882\" tg-height=\"624\" referrerpolicy=\"no-referrer\"></p>\n<p>Cassava said in a securities filing that \"certain government agencies have asked us to provide them with corporate information and documents\" and the Wall Street Journal, citing people familiar with the matter, that the agency was the SEC.</p>\n<p>\"We have been cooperating and will continue to cooperate with government authorities,\" Cassava said it is filing. \"No government agency has informed us that any wrongdoing has occurred by any party.\"</p>\n<p>The National Institutes of Health, which awarded $20 million in grants to Cassava and its academic collaborators since 2015 for drug development, is also examining the claims, according to the company’s chief executive officer.</p>\n<p>Cassava Sciences becameembroiled in controversyin August when Jordan Thomas, a partner and chair of the whistleblower representation practice at Labaton Sucharow, filed a citizen's petition with the U.S. Food and Drug Administration seeking to&nbsp;halt to trials of simufilam.</p>\n<p>On Wednesday, Thomas wrote a letter to acting U.S. Food and Drug Administration Janet Woodcock saying \"my clients’ worst fears about Cassava Sciences appear to have been true.\"</p>\n<p>Thomas identified his clients as&nbsp;David Bredt, former neuroscience research chief at Johnson &amp; Johnson&nbsp;(<b>JNJ</b>) Report&nbsp;and Eli Lilly &amp; Co.&nbsp;(<b>LLY</b>) , and Geoffrey Pitt, a cardiologist and professor at Weill Cornell Medicine</p>\n<p>\"Due to their serious concerns about simufilam and related research by Cassava,\" Thomas said, \"and at great personal and professional risk, my whistleblower clients, along with other prominent doctors and scientists, have voluntarily gone on the record.\"</p>\n<p>Bredt and Pitt wrote that Cassava’s research include images of experiments that appear to have been manipulated using software such as Photoshop.</p>\n<p>Thomas said that \"increasingly evidence suggests that Cassava has doctored its research and clinical trial results, duped peer-reviewed journals, used the tainted science to trick the NIH and FDA into approving grants and clinical trials.\"</p>\n<p>In addition, the company \"misled investors by touting their grants and clinical trials without disclosing their troubling research practices, and withheld material information about the true nature of its drug from vulnerable Alzheimer’s Disease patients.\"</p>\n<p>The FDA has a duty, Thomas said,&nbsp;\"to immediately halt the simufilam clinical trials, conduct a rigorous audit of all the company’s research and clinical trial results, and report the agency’s findings to interested law enforcement and regulatory authorities.\"</p>\n<p>Cassava did not immediately respond to a request for comment, but Chief Executive Remi Barbier has said that short sellers have abused the FDA’s petition process.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cassava Sciences Stock Tumbles on News of SEC Investigation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCassava Sciences Stock Tumbles on News of SEC Investigation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 10:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/cassava-sciences-stock-tumbles-on-news-of-sec-investigation><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The biotech faces claims of manipulating research results of its Alzheimer’s drug.\n$Cassava Sciences (SAVA)$ plummeted Wednesday after disclosing that \"certain government agencies\", which reportedly ...</p>\n\n<a href=\"https://www.thestreet.com/investing/cassava-sciences-stock-tumbles-on-news-of-sec-investigation\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SAVA":"Cassava Sciences Inc"},"source_url":"https://www.thestreet.com/investing/cassava-sciences-stock-tumbles-on-news-of-sec-investigation","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161909759","content_text":"The biotech faces claims of manipulating research results of its Alzheimer’s drug.\n$Cassava Sciences (SAVA)$ plummeted Wednesday after disclosing that \"certain government agencies\", which reportedly included the Securities and Exchange Commission, were investing claims the biotech manipulated research results of its experimental Alzheimer’s drug, simufilam.\nShares of the Austin, Texas company were down more than 23% to $47.07 Wednesday.\n\nCassava said in a securities filing that \"certain government agencies have asked us to provide them with corporate information and documents\" and the Wall Street Journal, citing people familiar with the matter, that the agency was the SEC.\n\"We have been cooperating and will continue to cooperate with government authorities,\" Cassava said it is filing. \"No government agency has informed us that any wrongdoing has occurred by any party.\"\nThe National Institutes of Health, which awarded $20 million in grants to Cassava and its academic collaborators since 2015 for drug development, is also examining the claims, according to the company’s chief executive officer.\nCassava Sciences becameembroiled in controversyin August when Jordan Thomas, a partner and chair of the whistleblower representation practice at Labaton Sucharow, filed a citizen's petition with the U.S. Food and Drug Administration seeking to halt to trials of simufilam.\nOn Wednesday, Thomas wrote a letter to acting U.S. Food and Drug Administration Janet Woodcock saying \"my clients’ worst fears about Cassava Sciences appear to have been true.\"\nThomas identified his clients as David Bredt, former neuroscience research chief at Johnson & Johnson (JNJ) Report and Eli Lilly & Co. (LLY) , and Geoffrey Pitt, a cardiologist and professor at Weill Cornell Medicine\n\"Due to their serious concerns about simufilam and related research by Cassava,\" Thomas said, \"and at great personal and professional risk, my whistleblower clients, along with other prominent doctors and scientists, have voluntarily gone on the record.\"\nBredt and Pitt wrote that Cassava’s research include images of experiments that appear to have been manipulated using software such as Photoshop.\nThomas said that \"increasingly evidence suggests that Cassava has doctored its research and clinical trial results, duped peer-reviewed journals, used the tainted science to trick the NIH and FDA into approving grants and clinical trials.\"\nIn addition, the company \"misled investors by touting their grants and clinical trials without disclosing their troubling research practices, and withheld material information about the true nature of its drug from vulnerable Alzheimer’s Disease patients.\"\nThe FDA has a duty, Thomas said, \"to immediately halt the simufilam clinical trials, conduct a rigorous audit of all the company’s research and clinical trial results, and report the agency’s findings to interested law enforcement and regulatory authorities.\"\nCassava did not immediately respond to a request for comment, but Chief Executive Remi Barbier has said that short sellers have abused the FDA’s petition process.","news_type":1},"isVote":1,"tweetType":1,"viewCount":151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878536636,"gmtCreate":1637204700313,"gmtModify":1637204700313,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878536636","repostId":"1155680084","repostType":4,"repost":{"id":"1155680084","pubTimestamp":1637201163,"share":"https://www.laohu8.com/m/news/1155680084?lang=&edition=full","pubTime":"2021-11-18 10:06","market":"us","language":"en","title":"Elon Musk has sold more Tesla shares than he needs to pay current tax bill ","url":"https://stock-news.laohu8.com/highlight/detail?id=1155680084","media":"Marketwatch","summary":"DETROIT — Elon Musk is selling more Tesla shares than he needs to pay current tax obligations, and e","content":"<p>DETROIT — Elon Musk is selling more Tesla shares than he needs to pay current tax obligations, and experts say he’s either converting part of his fortune from stock to cash, or he’s saving for bigger tax bills that will come due next year.</p>\n<p>As of early Wednesday, Musk had sold roughly 8.2 million shares in the electric car and solar panel maker in the past nine days, worth a total of just over $8.8 billion.</p>\n<p>Of those, Musk sold 2.8 million shares worth about $3 billion specifically to pay taxes on three tranches of stock options that he exercised this week, according to filings with the U.S. Securities and Exchange Commission. That means he has sold roughly $5 billion more in shares than he needs at present.</p>\n<p>Under a compensation plan from 2012, Musk has options to buy 26.4 million shares. The options expire next year, and the tax bill will come due. Wedbush analyst Daniel Ives estimates the bill to be $10 billion to $15 billion, depending on the stock price. Musk’s options so far allowed him to buy shares at $6.24 each, and the stock is selling for around $1,080.</p>\n<p>Erik Gordon, a University of Michigan business and law professor, questioned why Musk would sell that many shares now to pay obligations that come due next year. He said accruing for future tax liabilities makes sense only if Musk expects the stock price to drop.</p>\n<p>“If you think the stock is going to go up, or if you think the stock is going to stay the same, you wouldn’t be selling extra shares,” he said.</p>\n<p>On Nov. 6, Musk asked his 60 million Twitter followers if he should sell some of his Tesla TSLA, +3.25% stock. “Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my stock,” he wrote. According to Musk, 58% of those who responded said yes.</p>\n<p>Musk also conceded his wealth is tied up in stock, tweeting that he doesn’t get a cash salary or bonus from anywhere. “I have only stock, thus the only way for me to pay taxes personally is to sell stock,” he wrote.</p>\n<p>Musk started selling last Monday, and as of Wednesday, he had liquidated about 5% of his holdings. His federal tax obligations could be as high as 40% on proceeds from some of the sales, said Brad Badertscher, an accounting professor at the University of Notre Dame.</p>\n<p>Musk could have cut his tax bill on the options in half if he had exercised the options and waited a year to sell the shares, Badertscher said. That’s because with an immediate sale, the gain is taxed as ordinary income. In a year, Musk would pay the much lower capital gains rate, he said.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk has sold more Tesla shares than he needs to pay current tax bill </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk has sold more Tesla shares than he needs to pay current tax bill \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 10:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/elon-musk-has-sold-more-tesla-shares-than-he-needs-to-pay-current-tax-bill-01637190117?mod=newsviewer_click><strong>Marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DETROIT — Elon Musk is selling more Tesla shares than he needs to pay current tax obligations, and experts say he’s either converting part of his fortune from stock to cash, or he’s saving for bigger ...</p>\n\n<a href=\"https://www.marketwatch.com/story/elon-musk-has-sold-more-tesla-shares-than-he-needs-to-pay-current-tax-bill-01637190117?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/story/elon-musk-has-sold-more-tesla-shares-than-he-needs-to-pay-current-tax-bill-01637190117?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1155680084","content_text":"DETROIT — Elon Musk is selling more Tesla shares than he needs to pay current tax obligations, and experts say he’s either converting part of his fortune from stock to cash, or he’s saving for bigger tax bills that will come due next year.\nAs of early Wednesday, Musk had sold roughly 8.2 million shares in the electric car and solar panel maker in the past nine days, worth a total of just over $8.8 billion.\nOf those, Musk sold 2.8 million shares worth about $3 billion specifically to pay taxes on three tranches of stock options that he exercised this week, according to filings with the U.S. Securities and Exchange Commission. That means he has sold roughly $5 billion more in shares than he needs at present.\nUnder a compensation plan from 2012, Musk has options to buy 26.4 million shares. The options expire next year, and the tax bill will come due. Wedbush analyst Daniel Ives estimates the bill to be $10 billion to $15 billion, depending on the stock price. Musk’s options so far allowed him to buy shares at $6.24 each, and the stock is selling for around $1,080.\nErik Gordon, a University of Michigan business and law professor, questioned why Musk would sell that many shares now to pay obligations that come due next year. He said accruing for future tax liabilities makes sense only if Musk expects the stock price to drop.\n“If you think the stock is going to go up, or if you think the stock is going to stay the same, you wouldn’t be selling extra shares,” he said.\nOn Nov. 6, Musk asked his 60 million Twitter followers if he should sell some of his Tesla TSLA, +3.25% stock. “Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my stock,” he wrote. According to Musk, 58% of those who responded said yes.\nMusk also conceded his wealth is tied up in stock, tweeting that he doesn’t get a cash salary or bonus from anywhere. “I have only stock, thus the only way for me to pay taxes personally is to sell stock,” he wrote.\nMusk started selling last Monday, and as of Wednesday, he had liquidated about 5% of his holdings. His federal tax obligations could be as high as 40% on proceeds from some of the sales, said Brad Badertscher, an accounting professor at the University of Notre Dame.\nMusk could have cut his tax bill on the options in half if he had exercised the options and waited a year to sell the shares, Badertscher said. That’s because with an immediate sale, the gain is taxed as ordinary income. In a year, Musk would pay the much lower capital gains rate, he said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847463409,"gmtCreate":1636546529729,"gmtModify":1636546529907,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay 👌&nbsp;","listText":"Okay 👌&nbsp;","text":"Okay 👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847463409","repostId":"1153527139","repostType":4,"repost":{"id":"1153527139","pubTimestamp":1636545864,"share":"https://www.laohu8.com/m/news/1153527139?lang=&edition=full","pubTime":"2021-11-10 20:04","market":"us","language":"en","title":"Tesla Further Extends Delivery Time For Model Y Standard Range In China","url":"https://stock-news.laohu8.com/highlight/detail?id=1153527139","media":"Benzinga","summary":"Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in Chi","content":"<p><b>Tesla</b>&nbsp;<b>Inc’s</b>&nbsp;mid-size sports utility vehicle&nbsp;<b>ModelY</b>&nbsp;would now take even longer with deliveries in China, the electric vehicle maker’s website shows.</p>\n<p><b>What Happened:</b>The delivery time for the $43,200 Model Y standard range is now stretched to 10-14 weeks, from the earlier&nbsp;6-10 weeks range.</p>\n<p>The delivery for the Long Range and the Performance variant is estimated to take place in the fourth quarter; cnEVpost first&nbsp;reported&nbsp;on the development.</p>\n<p><b>Why It Matters:</b>Tesla launched the locally made Model Y standard range in July and started customer deliveries on August 26. The entry-level variant of Model Y uses CATL's more affordable lithium iron phosphate batteries.</p>\n<p>The&nbsp;<b>Elon</b>&nbsp;<b>Musk</b>-led company&nbsp;sold 54,391 electric vehicles&nbsp;to dealers in China in October, a rise of 348% on a year-on-year basis, as per China Passenger Car Association.</p>\n<p><b>Price Action:</b>Tesla shares closed 11.99% lower at $1,023.50 a share on Tuesday.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Further Extends Delivery Time For Model Y Standard Range In China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Further Extends Delivery Time For Model Y Standard Range In China\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 20:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in China, the electric vehicle maker’s website shows.\nWhat Happened:The delivery time for the $43,200 ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153527139","content_text":"Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in China, the electric vehicle maker’s website shows.\nWhat Happened:The delivery time for the $43,200 Model Y standard range is now stretched to 10-14 weeks, from the earlier 6-10 weeks range.\nThe delivery for the Long Range and the Performance variant is estimated to take place in the fourth quarter; cnEVpost first reported on the development.\nWhy It Matters:Tesla launched the locally made Model Y standard range in July and started customer deliveries on August 26. The entry-level variant of Model Y uses CATL's more affordable lithium iron phosphate batteries.\nThe Elon Musk-led company sold 54,391 electric vehicles to dealers in China in October, a rise of 348% on a year-on-year basis, as per China Passenger Car Association.\nPrice Action:Tesla shares closed 11.99% lower at $1,023.50 a share on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841619557,"gmtCreate":1635905743400,"gmtModify":1635905743400,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841619557","repostId":"1186977790","repostType":4,"repost":{"id":"1186977790","pubTimestamp":1635905359,"share":"https://www.laohu8.com/m/news/1186977790?lang=&edition=full","pubTime":"2021-11-03 10:09","market":"us","language":"en","title":"KFC Wanted to ‘Beat Us Down,’ Pilgrim’s Pride Witness Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1186977790","media":"Bloomberg","summary":"KFC Corp.’s top price negotiator told executives for Pilgrim’s Pride Corp. in 2017 that “he was goin","content":"<p>KFC Corp.’s top price negotiator told executives for Pilgrim’s Pride Corp. in 2017 that “he was going to beat us down with a hammer and a baseball bat” as payback for three years of high chicken prices. That’s according to the government’s star witness in the trial of 10 chicken-industry workers and executives charged with criminal price-fixing.</p>\n<p>Robert Bryant, a longtime Pilgrim’s Pride employee currently on leave, testified in Denver about talks between Pilgrim’s, the No. 2 U.S. chicken producer, and the company that manages supply for Yum! Brands Inc.’s KFC, Pizza Hut and Taco Bell fast-food restaurants. The KFC negotiator, Pete Suerken, was working on a new contract with Pilgrim’s after a three-year deal that included unprecedented price increases, according to Bryant, who took the stand Monday and Tuesday.</p>\n<p>At the heart of the matter is whether the defendants conspired to inflate prices in the $95 billion U.S. market. During opening remarks last week, Justice Department lawyer Michael Koenig said the insiders, who worked for competing chicken companies including top producer Tyson Foods Inc., came together to create “massive, historic price increases” and stonewalled efforts by customers including KFC to negotiate them lower.</p>\n<p>The defendants, who include former Pilgrim’s chief executives Jayson Penn and William Lovette, have all pleaded not guilty and are fighting the charges in the trial. They claim there was no conspiracy to fix prices or rig bids. Efforts to discover details of competitors’ prices were legal and chicken prices were the result of market forces, not illegal collusion, they said.</p>\n<p>Bryant is taking the stand with immunity as a result of a Pilgrim’s plea deal, and his testimony has been hotly anticipated as key to the government’s case. On cross-examination, Bryant admitted that he had lied to the FBI “multiple times” on matters unrelated to the price-fixing investigation. The subject of Bryant’s lies wasn’t made public.</p>\n<p>‘Two-Way Street’</p>\n<p>Bryant on Monday coolly pointed out for jurors the former colleagues and industry contacts who face charges that could land them in prison and bring million-dollar fines. He said Pilgrim’s and its competitors routinely shared information about pricing and planned bids “to increase prices or to limit a decrease, depending on the market conditions.”</p>\n<p>“My understanding is it was a two-way street,” Bryant told jurors. “We received their prices and they received ours.”</p>\n<p>He testified that the goal in 2014 was to raise prices. In 2017, the aim was to limit the damage at a time when prices were declining. KFC that year forced Pilgrim’s Pride to reduce prices and decreased the company’s volume, in retaliation for the earlier contract.</p>\n<p>“He was upset about 2014,” Bryant said.</p>\n<p>Prosecutors showed jurors Bryant’s handwritten notes from 2017 showing what he testified were planned bids by five Pilgrim’s competitors, including Tyson. Suppliers bid every year on contracts with the biggest fast-food companies, including KFC, Chick-fil-A Inc. and Popeyes Louisiana Kitchen Inc. The contracts help set the business prospects for the companies as well as the prices paid by people who eat chicken.</p>\n<p>‘Pandemic Profiteering’</p>\n<p>Bryant conceded, under cross-examination by lawyer Michael Feldberg, that the numbers in his notes didn’t match the actual prices that were later charged by the companies. Feldberg pressed Bryant to acknowledge market influences on chicken prices, including severe shortages in 2014. And he suggested Bryant is lying about an agreement among the defendants to fix prices to curry favor with the government and avoid facing criminal charges himself.</p>\n<p>While the evidence covers alleged efforts to fix prices and rig bids from 2012 to early 2019, the findings could set the stage for further moves against the industry, which has caught the ire of the Biden administration. Officials have said meatpackers engaged in “pandemic profiteering,” squeezing consumers and farmers.</p>\n<p>Greeley, Colorado-based Pilgrim’s Pride, a unit of Brazilian food giant JBS SA, pleaded guilty to price-fixing conspiracy in February and was sentenced to pay $108 million in fines. As part of the plea deal, Pilgrim’s agreed to cooperate with the government investigation. In a statement last week, the company said it is “focused on maintaining our commitment to fair and honest competition in compliance with U.S. antitrust laws.”</p>\n<p>Tyson last year said it was cooperating with the Justice Department.</p>\n<p>10 Defendants</p>\n<p>In addition to Penn and Lovette, prosecutors charged Roger Austin, a former vice president of Pilgrim’s; Mikell Fries, president of Claxton Poultry Farms Inc.; Scott Brady, a Claxton vice president; Timothy Mulrenin, a Perdue Farms Inc. executive who previously worked at Tyson; William Kantola, a Koch Foods Inc. sales executive; Jimmie Lee Little, a former Pilgrim’s Pride sales director; Gary Brian Roberts, a Case Farms Inc. employee who had previously worked at Tyson; and Rickie Blake, a former director and manager at George’s Inc.</p>\n<p>All are charged with violating the Sherman Act, a law that dates to 1890 and is intended to preserve competition in U.S. markets. Each defendant is charged with a single count of conspiracy to restrain trade, which carries a maximum of 10 years in prison. Little is also charged with obstruction of justice, which has a 20-year maximum.</p>\n<p>Four other former Pilgrim’s employees were charged separately and face trial next year.</p>\n<p>The case is U.S. v. Penn, 20-cr-00152, U.S. District Court, District of Colorado (Denver).</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KFC Wanted to ‘Beat Us Down,’ Pilgrim’s Pride Witness Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKFC Wanted to ‘Beat Us Down,’ Pilgrim’s Pride Witness Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-03 10:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/kfc-wanted-beat-us-down-202810293.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KFC Corp.’s top price negotiator told executives for Pilgrim’s Pride Corp. in 2017 that “he was going to beat us down with a hammer and a baseball bat” as payback for three years of high chicken ...</p>\n\n<a href=\"https://finance.yahoo.com/news/kfc-wanted-beat-us-down-202810293.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"YUM":"百胜餐饮集团"},"source_url":"https://finance.yahoo.com/news/kfc-wanted-beat-us-down-202810293.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186977790","content_text":"KFC Corp.’s top price negotiator told executives for Pilgrim’s Pride Corp. in 2017 that “he was going to beat us down with a hammer and a baseball bat” as payback for three years of high chicken prices. That’s according to the government’s star witness in the trial of 10 chicken-industry workers and executives charged with criminal price-fixing.\nRobert Bryant, a longtime Pilgrim’s Pride employee currently on leave, testified in Denver about talks between Pilgrim’s, the No. 2 U.S. chicken producer, and the company that manages supply for Yum! Brands Inc.’s KFC, Pizza Hut and Taco Bell fast-food restaurants. The KFC negotiator, Pete Suerken, was working on a new contract with Pilgrim’s after a three-year deal that included unprecedented price increases, according to Bryant, who took the stand Monday and Tuesday.\nAt the heart of the matter is whether the defendants conspired to inflate prices in the $95 billion U.S. market. During opening remarks last week, Justice Department lawyer Michael Koenig said the insiders, who worked for competing chicken companies including top producer Tyson Foods Inc., came together to create “massive, historic price increases” and stonewalled efforts by customers including KFC to negotiate them lower.\nThe defendants, who include former Pilgrim’s chief executives Jayson Penn and William Lovette, have all pleaded not guilty and are fighting the charges in the trial. They claim there was no conspiracy to fix prices or rig bids. Efforts to discover details of competitors’ prices were legal and chicken prices were the result of market forces, not illegal collusion, they said.\nBryant is taking the stand with immunity as a result of a Pilgrim’s plea deal, and his testimony has been hotly anticipated as key to the government’s case. On cross-examination, Bryant admitted that he had lied to the FBI “multiple times” on matters unrelated to the price-fixing investigation. The subject of Bryant’s lies wasn’t made public.\n‘Two-Way Street’\nBryant on Monday coolly pointed out for jurors the former colleagues and industry contacts who face charges that could land them in prison and bring million-dollar fines. He said Pilgrim’s and its competitors routinely shared information about pricing and planned bids “to increase prices or to limit a decrease, depending on the market conditions.”\n“My understanding is it was a two-way street,” Bryant told jurors. “We received their prices and they received ours.”\nHe testified that the goal in 2014 was to raise prices. In 2017, the aim was to limit the damage at a time when prices were declining. KFC that year forced Pilgrim’s Pride to reduce prices and decreased the company’s volume, in retaliation for the earlier contract.\n“He was upset about 2014,” Bryant said.\nProsecutors showed jurors Bryant’s handwritten notes from 2017 showing what he testified were planned bids by five Pilgrim’s competitors, including Tyson. Suppliers bid every year on contracts with the biggest fast-food companies, including KFC, Chick-fil-A Inc. and Popeyes Louisiana Kitchen Inc. The contracts help set the business prospects for the companies as well as the prices paid by people who eat chicken.\n‘Pandemic Profiteering’\nBryant conceded, under cross-examination by lawyer Michael Feldberg, that the numbers in his notes didn’t match the actual prices that were later charged by the companies. Feldberg pressed Bryant to acknowledge market influences on chicken prices, including severe shortages in 2014. And he suggested Bryant is lying about an agreement among the defendants to fix prices to curry favor with the government and avoid facing criminal charges himself.\nWhile the evidence covers alleged efforts to fix prices and rig bids from 2012 to early 2019, the findings could set the stage for further moves against the industry, which has caught the ire of the Biden administration. Officials have said meatpackers engaged in “pandemic profiteering,” squeezing consumers and farmers.\nGreeley, Colorado-based Pilgrim’s Pride, a unit of Brazilian food giant JBS SA, pleaded guilty to price-fixing conspiracy in February and was sentenced to pay $108 million in fines. As part of the plea deal, Pilgrim’s agreed to cooperate with the government investigation. In a statement last week, the company said it is “focused on maintaining our commitment to fair and honest competition in compliance with U.S. antitrust laws.”\nTyson last year said it was cooperating with the Justice Department.\n10 Defendants\nIn addition to Penn and Lovette, prosecutors charged Roger Austin, a former vice president of Pilgrim’s; Mikell Fries, president of Claxton Poultry Farms Inc.; Scott Brady, a Claxton vice president; Timothy Mulrenin, a Perdue Farms Inc. executive who previously worked at Tyson; William Kantola, a Koch Foods Inc. sales executive; Jimmie Lee Little, a former Pilgrim’s Pride sales director; Gary Brian Roberts, a Case Farms Inc. employee who had previously worked at Tyson; and Rickie Blake, a former director and manager at George’s Inc.\nAll are charged with violating the Sherman Act, a law that dates to 1890 and is intended to preserve competition in U.S. markets. Each defendant is charged with a single count of conspiracy to restrain trade, which carries a maximum of 10 years in prison. Little is also charged with obstruction of justice, which has a 20-year maximum.\nFour other former Pilgrim’s employees were charged separately and face trial next year.\nThe case is U.S. v. Penn, 20-cr-00152, U.S. District Court, District of Colorado (Denver).","news_type":1},"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841634688,"gmtCreate":1635905542092,"gmtModify":1635905542092,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841634688","repostId":"2180736486","repostType":4,"isVote":1,"tweetType":1,"viewCount":82,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849836891,"gmtCreate":1635740774157,"gmtModify":1635740774157,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849836891","repostId":"1164035523","repostType":4,"repost":{"id":"1164035523","pubTimestamp":1635736469,"share":"https://www.laohu8.com/m/news/1164035523?lang=&edition=full","pubTime":"2021-11-01 11:14","market":"us","language":"en","title":"2 Growth Stocks That Could Deliver 1,000% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=1164035523","media":"Motley Fool","summary":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders h","content":"<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist&nbsp;<b>Axsome Therapeutics</b>, the cancer specialist&nbsp;<b>Exelixis</b>, and the electric car pioneer&nbsp;<b>Tesla</b>&nbsp;have all delivered tenfold returns for investors who bought these names at their low points.</p>\n<p>Which stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist&nbsp;<b>Mereo BioPharma Group</b>(NASDAQ:MREO)and the diabetes-focused medical device company&nbsp;<b>Senseonics Holdings</b>(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced&nbsp;healthcare stocks&nbsp;have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.</p>\n<p>Here's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.</p>\n<p><b>Mereo BioPharma: A bet on the future of immunotherapy</b></p>\n<p>The London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.</p>\n<p>What's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the&nbsp;anti-TIGIT therapy&nbsp;known as etigilimab. Several major drug companies, such as&nbsp;<b>BeiGene</b>,<b>Bristol Myers Squibb</b>,<b>Merck</b>, and&nbsp;<b>Roche</b>, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.</p>\n<p>As things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.</p>\n<p>What's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.</p>\n<p><b>Senseonic: A rising tide lifts all boats</b></p>\n<p>Senseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10%&nbsp;<i>per year</i>&nbsp;over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.</p>\n<p>So far, Senseonics has only captured a&nbsp;small sliver&nbsp;of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company&nbsp;submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.</p>\n<p>Why does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from&nbsp;<b>DexCom</b>&nbsp;and&nbsp;<b>Abbott Laboratories</b>, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.</p>\n<p>What's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.</p>\n<p>All told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks That Could Deliver 1,000% Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks That Could Deliver 1,000% Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SENS":"Senseonics Holdings,Inc.","MREO":"Mereo Biopharma Group Plc"},"source_url":"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164035523","content_text":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist Axsome Therapeutics, the cancer specialist Exelixis, and the electric car pioneer Tesla have all delivered tenfold returns for investors who bought these names at their low points.\nWhich stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist Mereo BioPharma Group(NASDAQ:MREO)and the diabetes-focused medical device company Senseonics Holdings(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced healthcare stocks have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.\nHere's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.\nMereo BioPharma: A bet on the future of immunotherapy\nThe London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.\nWhat's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the anti-TIGIT therapy known as etigilimab. Several major drug companies, such as BeiGene,Bristol Myers Squibb,Merck, and Roche, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.\nAs things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.\nWhat's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.\nSenseonic: A rising tide lifts all boats\nSenseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10% per year over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.\nSo far, Senseonics has only captured a small sliver of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.\nWhy does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from DexCom and Abbott Laboratories, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.\nWhat's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.\nAll told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849838403,"gmtCreate":1635740738541,"gmtModify":1635740738634,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849838403","repostId":"2179250221","repostType":4,"repost":{"id":"2179250221","pubTimestamp":1635721559,"share":"https://www.laohu8.com/m/news/2179250221?lang=&edition=full","pubTime":"2021-11-01 07:05","market":"us","language":"en","title":"Federal Reserve decision, October jobs report: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2179250221","media":"Yahoo Finance","summary":"The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set th","content":"<p><img src=\"https://static.tigerbbs.com/790c3fdfdc38fa2b5b3a13d89fb1959a\" tg-width=\"1878\" tg-height=\"2940\" width=\"100%\" height=\"auto\"></p>\n<p>The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also await more data on the U.S. economic recovery with the Labor Department's monthly jobs report later this week.</p>\n<p>The Federal Open Market Committee's (FOMC) November meeting will take place from Tuesday to Wednesday, with the policy statement and press conference from the meeting serving as the central bank's penultimate opportunity this year to announce formal plans to begin rolling back its crisis-era quantitative easing program. For the past year-and-a-half, the central bank has been purchasing $120 billion per month in agency mortgage-backed securities and Treasuries, as <a href=\"https://laohu8.com/S/AONE.U\">one</a> major tool to support the economy during the pandemic.</p>\n<p>In late September, the FOMC's latest monetary policy statement and press conference from Federal Reserve Chair Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> suggested the central bank was apt to announce the start of tapering before year-end, and continue the tapering process until \"around the middle of next year.\"</p>\n<p>\"The upcoming FOMC meeting will be important for three reasons: 1) the announcement of tapering; 2) guidance around what tapering means for the path of hikes; and 3) nuanced changes in views around inflation risks given recent data,\" wrote <a href=\"https://laohu8.com/S/BAC\">Bank of America</a> economist Michelle Meyer in a note.</p>\n<p>\"The statement that announces the new pace of asset purchases will be followed by a note regarding flexibility stating that asset purchases are not on a pre-set course and will depend on the outlook for the labor market and inflation as well as an assessment of the efficacy of asset purchases,\" she predicted.</p>\n<p>She noted that Powell may also use the press conference to reiterate that the end of tapering would not necessarily indicate the start of rate hikes, and that both policy actions are distinct. In previous public remarks, Powell has already made a similar point in previous public remarks, saying, \"the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff.\"</p>\n<p>Given the market has been anticipating the start to tapering for months now, speculation around when the Fed will make a move on interest rates has become a point of particular interest to investors. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> and economists have mulled whether the Fed may need to act more quickly than previously telegraphed on adjusting interest rates to stave off inflation, which has proven more long-lasting than some had suggested.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f0f0ae63a784eef5578397df02340483\" tg-width=\"4932\" tg-height=\"3288\" referrerpolicy=\"no-referrer\"><span>WASHINGTON, DC - SEPTEMBER 24: Federal Reserve Board Chairman Jerome Powell testifies during a Senate Banking Committee hearing on Capitol Hill on September 24, 2020 in Washington, DC. Powell and U.S. Treasury Secretary Steve Mnuchin are testifying about the CARES Act and the economic effects of the coronavirus pandemic. (Photo by Drew Angerer/Getty Images)Drew Angerer via Getty Images</span></p>\n<p>In September, core personal consumption expenditures — the Fed's preferred gauge of underlying inflation — rose 3.6% over last year for a fourth consecutive month, coming in at the fastest clip since 1991. And earlier this month, Powell acknowledged in public remarks that the supply chain constraints and shortages that spurred the latest rise in prices are \"likely to last longer than previously expected, likely well into next year.\"</p>\n<p>While the central bank will not release an updated Summary of Economic Projections with their policy statement on Wednesday, the latest projections from the September meeting suggested the committee was split on rate hikes for 2022, with nine members seeing no rate hikes by the end of next year while the other nine members saw at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> hike.</p>\n<p>\"I think the Fed has pretty well determined to start the taper pretty quickly. We expect them to announce it next week and then start it soon thereafter, so that's pretty well carved in stone,\" Kathy Jones, <a href=\"https://laohu8.com/S/SCHW\">Charles Schwab</a> chief fixed income strategist, told Yahoo Finance Live last week. \"I think the big debate now is how quickly the Fed moves toward actually raising rates. The expectation in the market has really shifted to expecting as many as two rate hikes in 2022 and 2023 ... that’s a pretty aggressive pace of tightening.\"</p>\n<h2>October jobs report</h2>\n<p>One of this week's most closely watched pieces of economic data will be the October jobs report, which is due for release on Friday from the Labor Department.</p>\n<p>Economists are looking to see a pick-up in the pace of hiring for October after a disappointing print in September, when just 194,000 non-farm payrolls returned versus the half million expected. Over the past two months, payroll gains averaged at just 280,000. The unemployment rate is expected to take another small step toward pre-pandemic levels in October as well, with the jobless rate anticipated to dip to 4.7% from 4.8% the prior month.</p>\n<p>Still, the labor market has still fallen short its pre-pandemic conditions on a number of fronts. The unemployment rate has yet to return to its 50-year low of 3.5% from February 2020. And as of September, the civilian labor force was still down by about 3.1 million individuals from pre-virus levels.</p>\n<p>One factor weighing on the labor market in August and September was the Delta variant, which may have deterred some workers from seeking employment in person for risk of infection. And an ongoing element dragging on the labor market's recovery has been a mismatch of supply and demand, with employers struggling to fill a near-record number of job openings while voluntary quits jumped to a historically high level.</p>\n<p>\"Next week’s October payrolls report will shed light on whether supply eased on diminishing constraints or if the labor market continues to face headwinds for now,\" wrote Rubeela Farooqi, chief U.S. economist for High Frequency Economics, in a note last week.</p>\n<p>But some data from the past couple weeks has reflected favorably on conditions in the labor market in October. Weekly new unemployment claims broke below 300,000 for the first time since the start of the pandemic during the survey week for the October jobs report, or the week that includes the 12th of the month. And in the Conference Board's October Consumer Confidence Index, just 10.6% of consumers said jobs were \"hard to get,\" down from 13.0% in September. That brought the Conference Board's closely watched labor market differential, or percentage of consumers saying jobs are \"hard to get\" subtracted from the percentage saying jobs \"are plentiful,\" to 45, or its highest level since 2000.</p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b><a href=\"https://laohu8.com/S/MRKT\">Markit</a> U.S. Manufacturing PMI, Oct. final (59.3 expected, 59.2 in September); Constructing spending, month-over-month, September (0.4% expected, 0.0% in August); ISM Manufacturing Index, Oct. (60.5 expected, 61.1 in September)</p></li>\n <li><p><b>Tuesday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Wednesday: </b>MBA Mortgage Applications, week ended Oct. 29 (0.3% during prior week); ADP Employment Change, Oct. (400,000 expected, 568,000 in September); ISM Services Index, October (62.0 expected, 61.9 in September); Factory Orders, September (-0.1% expected, 1.2% in August); Durable goods orders, September final (-0.4% in prior print; Durable goods orders excluding transportation, September final (0.4% in prior print); Non-defense capital goods orders excluding aircraft, September final (0.8% in prior print); Markit U.S. Services PMI, October final (58.2 expected, 58.2 in prior print); Markit U.S. Composite PMI, October final (57.3 in prior print); Federal Open Market Committee monetary policy decision</p></li>\n <li><p><b>Thursday: </b>Challenger job cuts, year-over-year, October (-84.9% in September); Initial jobless claims, week ended Oct. 30 (275,000 expected, 281,000 during prior week); Continuing claims, week ended Oct. 23 (2.147 million expected, 2.243 million during prior week); Non-farm productivity, Q3 preliminary (-3.2% expected, 2.1% in <a href=\"https://laohu8.com/S/QTWO\">Q2</a>); <a href=\"https://laohu8.com/S/UNT\">Unit</a> Labor Costs, Q3 preliminary (6.9% expected, 1.3% in Q2); Trade balance, September (-$80.1 billion expected, -$73.3 billion in August)</p></li>\n <li><p><b>Friday: </b>Change in non-farm payrolls, October (450,000 expected, 194,000 in September); Unemployment rate, October (4.7% expected, 4.8% in September); Average hourly earnings, month-over-month, October (4.7% expected, 4.8% in September); Average hourly earnings, year-over-year, October (4.9% expected, 4.6% in September); Labor Force Participation Rate, October (61.8% expected, 61.6% in September); Consumer Credit, September ($16.200 billion expected, $14.379 million in August)</p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><a href=\"https://laohu8.com/S/CLX\">Clorox</a> (CLX), <a href=\"https://laohu8.com/S/CAR\">Avis Budget</a> Group (<a href=\"https://laohu8.com/S/00699\">CAR</a>), ZoomInfo Technologies (ZI), <a href=\"https://laohu8.com/S/CHGG\">Chegg Inc</a>. (CHGG), <a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a> (FANG), The <a href=\"https://laohu8.com/S/SPG\">Simon Property</a> Group (SPG) after market close</p></li>\n <li><p><b>Tuesday: </b><a href=\"https://laohu8.com/S/UA.C\">Under Armour</a> (UAA), <a href=\"https://laohu8.com/S/EL\">Estee Lauder</a> (EL), <a href=\"https://laohu8.com/S/RL\">Ralph Lauren</a> (RL), Apollo Global Management (APO), Corsair Gaming (CRSR), <a href=\"https://laohu8.com/S/BLMN\">Bloomin' Brands</a> (BLMN), <a href=\"https://laohu8.com/S/COP\">ConocoPhillips</a> (COP), <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE), <a href=\"https://laohu8.com/S/GRPN\">Groupon</a> (GPN), <a href=\"https://laohu8.com/S/MPC\">Marathon</a> Petroleum (MPC) before market open; <a href=\"https://laohu8.com/S/MDLZ\">Mondelez</a> (MDLZ), T-Mobile (TMUS), <a href=\"https://laohu8.com/S/AKAM\">Akamai</a> (AKAM), <a href=\"https://laohu8.com/S/ATVI\">Activision Blizzard</a> (ATVI), Lyft (LYFT), <a href=\"https://laohu8.com/S/MTCH\">Match</a> Group (MTCH), <a href=\"https://laohu8.com/S/DVN\">Devon</a> Energy (DVN), <a href=\"https://laohu8.com/S/CHK\">Chesapeake</a> Energy (CHK), Coursera (COUR), <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG), <a href=\"https://laohu8.com/S/AMGN\">Amgen</a> (AMGN) after market close</p></li>\n <li><p><b>Wednesday: </b><a href=\"https://laohu8.com/S/HUM\">Humana</a> (HUM), <a href=\"https://laohu8.com/S/DISCA\">Discovery</a> Inc. (DISCA), The <a href=\"https://laohu8.com/S/NYT\">New York Times</a> (NYT), <a href=\"https://laohu8.com/S/NCLH\">Norwegian Cruise Line</a> Holdings (NCLH), <a href=\"https://laohu8.com/S/MAR\">Marriott</a> International (MAR), <a href=\"https://laohu8.com/S/CVS\">CVS Health</a> Corp. (CVS), <a href=\"https://laohu8.com/S/SBGI\">Sinclair Broadcast Group</a> (SBGI) before market open; <a href=\"https://laohu8.com/S/BKNG\">Booking Holdings</a> (BKNG), <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO), The <a href=\"https://laohu8.com/S/ALL\">Allstate</a> Corp. (ALL), <a href=\"https://laohu8.com/S/MGM\">MGM Resorts International</a> (MGM), $Take-<a href=\"https://laohu8.com/S/TWOA.U\">Two</a> Interactive Software(TTWO)$ (TTWO), <a href=\"https://laohu8.com/S/EA\">Electronic Arts</a> (EA), Vimeo (VMEO), <a href=\"https://laohu8.com/S/ETSY\">Etsy</a> (ETSY), <a href=\"https://laohu8.com/S/GDDY\">GoDaddy</a> (GDDY), <a href=\"https://laohu8.com/S/MRO\">Marathon</a> Oil Corp. (MRO), Roku (ROKU), <a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a> (QCOM) after market close</p></li>\n <li><p><b>Thursday: </b><a href=\"https://laohu8.com/S/CI\">Cigna</a> (CI), <a href=\"https://laohu8.com/S/W\">Wayfair</a> (W), ViacomCBS (VIAC), Nikola (NKLA), <a href=\"https://laohu8.com/S/DEX.AU\">Duke</a> Energy (DUK), <a href=\"https://laohu8.com/S/CTXS\">Citrix</a> Systems (CTXS), <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> (REGN), <a href=\"https://laohu8.com/S/HBI\">Hanesbrands</a> (HBI), Moderna (MRNA), <a href=\"https://laohu8.com/S/PLNT\">Planet Fitness</a> (PLNT), Vulcan Material (VMC), <a href=\"https://laohu8.com/S/K\">Kellogg</a> (K), <a href=\"https://laohu8.com/S/SQ\">Square</a> (SQ), Cloudflare (NET), <a href=\"https://laohu8.com/S/OXY\">Occidental</a> Petroleum (OXY), <a href=\"https://laohu8.com/S/UBER\">Uber</a> Technologies (UBER), <a href=\"https://laohu8.com/S/AFG\">American</a> International Group (AIG), <a href=\"https://laohu8.com/S/SHAK\">Shake Shack</a> (SHAK), iHeartMedia (IHRT), <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> (NVAX), IAC Interactive Corp. (IAC), Peloton (PTON), Dropbox (DBX), DataDog (DDOG), Pinterest (PINS), <a href=\"https://laohu8.com/S/SWKS\">Skyworks Solutions</a> (SWKS), <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE), Rocket Cos. (RKT), <a href=\"https://laohu8.com/S/LYV\">Live Nation Entertainment</a> (LYV), Airbnb (ABNB)</p></li>\n <li><p><b>Friday: </b><a href=\"https://laohu8.com/S/WYNN\">Wynn</a> Resorts (WYNN), Dish Networks (DISH), Dominion Energy (D), DraftKings (DKNG), <a href=\"https://laohu8.com/S/GT\">Goodyear</a> Tire and Rubber (GT), <a href=\"https://laohu8.com/S/CNK\">Cinemark</a> Holdings (CNK) before market open</p></li>\n</ul>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Federal Reserve decision, October jobs report: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFederal Reserve decision, October jobs report: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 07:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also ...</p>\n\n<a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EL":"雅诗兰黛","RL":"拉夫劳伦","COP":"康菲石油","CRSR":"Corsair Gaming, Inc.",".DJI":"道琼斯","UBER":"优步","APO":"阿波罗全球管理","BLMN":"Bloomin' Brands","ATVI":"动视暴雪","PFE":"辉瑞",".IXIC":"NASDAQ Composite","CLX":"高乐氏",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179250221","content_text":"The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also await more data on the U.S. economic recovery with the Labor Department's monthly jobs report later this week.\nThe Federal Open Market Committee's (FOMC) November meeting will take place from Tuesday to Wednesday, with the policy statement and press conference from the meeting serving as the central bank's penultimate opportunity this year to announce formal plans to begin rolling back its crisis-era quantitative easing program. For the past year-and-a-half, the central bank has been purchasing $120 billion per month in agency mortgage-backed securities and Treasuries, as one major tool to support the economy during the pandemic.\nIn late September, the FOMC's latest monetary policy statement and press conference from Federal Reserve Chair Jerome Powell suggested the central bank was apt to announce the start of tapering before year-end, and continue the tapering process until \"around the middle of next year.\"\n\"The upcoming FOMC meeting will be important for three reasons: 1) the announcement of tapering; 2) guidance around what tapering means for the path of hikes; and 3) nuanced changes in views around inflation risks given recent data,\" wrote Bank of America economist Michelle Meyer in a note.\n\"The statement that announces the new pace of asset purchases will be followed by a note regarding flexibility stating that asset purchases are not on a pre-set course and will depend on the outlook for the labor market and inflation as well as an assessment of the efficacy of asset purchases,\" she predicted.\nShe noted that Powell may also use the press conference to reiterate that the end of tapering would not necessarily indicate the start of rate hikes, and that both policy actions are distinct. In previous public remarks, Powell has already made a similar point in previous public remarks, saying, \"the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff.\"\nGiven the market has been anticipating the start to tapering for months now, speculation around when the Fed will make a move on interest rates has become a point of particular interest to investors. Investors and economists have mulled whether the Fed may need to act more quickly than previously telegraphed on adjusting interest rates to stave off inflation, which has proven more long-lasting than some had suggested.\nWASHINGTON, DC - SEPTEMBER 24: Federal Reserve Board Chairman Jerome Powell testifies during a Senate Banking Committee hearing on Capitol Hill on September 24, 2020 in Washington, DC. Powell and U.S. Treasury Secretary Steve Mnuchin are testifying about the CARES Act and the economic effects of the coronavirus pandemic. (Photo by Drew Angerer/Getty Images)Drew Angerer via Getty Images\nIn September, core personal consumption expenditures — the Fed's preferred gauge of underlying inflation — rose 3.6% over last year for a fourth consecutive month, coming in at the fastest clip since 1991. And earlier this month, Powell acknowledged in public remarks that the supply chain constraints and shortages that spurred the latest rise in prices are \"likely to last longer than previously expected, likely well into next year.\"\nWhile the central bank will not release an updated Summary of Economic Projections with their policy statement on Wednesday, the latest projections from the September meeting suggested the committee was split on rate hikes for 2022, with nine members seeing no rate hikes by the end of next year while the other nine members saw at least one hike.\n\"I think the Fed has pretty well determined to start the taper pretty quickly. We expect them to announce it next week and then start it soon thereafter, so that's pretty well carved in stone,\" Kathy Jones, Charles Schwab chief fixed income strategist, told Yahoo Finance Live last week. \"I think the big debate now is how quickly the Fed moves toward actually raising rates. The expectation in the market has really shifted to expecting as many as two rate hikes in 2022 and 2023 ... that’s a pretty aggressive pace of tightening.\"\nOctober jobs report\nOne of this week's most closely watched pieces of economic data will be the October jobs report, which is due for release on Friday from the Labor Department.\nEconomists are looking to see a pick-up in the pace of hiring for October after a disappointing print in September, when just 194,000 non-farm payrolls returned versus the half million expected. Over the past two months, payroll gains averaged at just 280,000. The unemployment rate is expected to take another small step toward pre-pandemic levels in October as well, with the jobless rate anticipated to dip to 4.7% from 4.8% the prior month.\nStill, the labor market has still fallen short its pre-pandemic conditions on a number of fronts. The unemployment rate has yet to return to its 50-year low of 3.5% from February 2020. And as of September, the civilian labor force was still down by about 3.1 million individuals from pre-virus levels.\nOne factor weighing on the labor market in August and September was the Delta variant, which may have deterred some workers from seeking employment in person for risk of infection. And an ongoing element dragging on the labor market's recovery has been a mismatch of supply and demand, with employers struggling to fill a near-record number of job openings while voluntary quits jumped to a historically high level.\n\"Next week’s October payrolls report will shed light on whether supply eased on diminishing constraints or if the labor market continues to face headwinds for now,\" wrote Rubeela Farooqi, chief U.S. economist for High Frequency Economics, in a note last week.\nBut some data from the past couple weeks has reflected favorably on conditions in the labor market in October. Weekly new unemployment claims broke below 300,000 for the first time since the start of the pandemic during the survey week for the October jobs report, or the week that includes the 12th of the month. And in the Conference Board's October Consumer Confidence Index, just 10.6% of consumers said jobs were \"hard to get,\" down from 13.0% in September. That brought the Conference Board's closely watched labor market differential, or percentage of consumers saying jobs are \"hard to get\" subtracted from the percentage saying jobs \"are plentiful,\" to 45, or its highest level since 2000.\nEconomic calendar\n\nMonday: Markit U.S. Manufacturing PMI, Oct. final (59.3 expected, 59.2 in September); Constructing spending, month-over-month, September (0.4% expected, 0.0% in August); ISM Manufacturing Index, Oct. (60.5 expected, 61.1 in September)\nTuesday: No notable reports scheduled for release\nWednesday: MBA Mortgage Applications, week ended Oct. 29 (0.3% during prior week); ADP Employment Change, Oct. (400,000 expected, 568,000 in September); ISM Services Index, October (62.0 expected, 61.9 in September); Factory Orders, September (-0.1% expected, 1.2% in August); Durable goods orders, September final (-0.4% in prior print; Durable goods orders excluding transportation, September final (0.4% in prior print); Non-defense capital goods orders excluding aircraft, September final (0.8% in prior print); Markit U.S. Services PMI, October final (58.2 expected, 58.2 in prior print); Markit U.S. Composite PMI, October final (57.3 in prior print); Federal Open Market Committee monetary policy decision\nThursday: Challenger job cuts, year-over-year, October (-84.9% in September); Initial jobless claims, week ended Oct. 30 (275,000 expected, 281,000 during prior week); Continuing claims, week ended Oct. 23 (2.147 million expected, 2.243 million during prior week); Non-farm productivity, Q3 preliminary (-3.2% expected, 2.1% in Q2); Unit Labor Costs, Q3 preliminary (6.9% expected, 1.3% in Q2); Trade balance, September (-$80.1 billion expected, -$73.3 billion in August)\nFriday: Change in non-farm payrolls, October (450,000 expected, 194,000 in September); Unemployment rate, October (4.7% expected, 4.8% in September); Average hourly earnings, month-over-month, October (4.7% expected, 4.8% in September); Average hourly earnings, year-over-year, October (4.9% expected, 4.6% in September); Labor Force Participation Rate, October (61.8% expected, 61.6% in September); Consumer Credit, September ($16.200 billion expected, $14.379 million in August)\n\nEarnings calendar\n\nMonday: Clorox (CLX), Avis Budget Group (CAR), ZoomInfo Technologies (ZI), Chegg Inc. (CHGG), Diamondback Energy (FANG), The Simon Property Group (SPG) after market close\nTuesday: Under Armour (UAA), Estee Lauder (EL), Ralph Lauren (RL), Apollo Global Management (APO), Corsair Gaming (CRSR), Bloomin' Brands (BLMN), ConocoPhillips (COP), Pfizer (PFE), Groupon (GPN), Marathon Petroleum (MPC) before market open; Mondelez (MDLZ), T-Mobile (TMUS), Akamai (AKAM), Activision Blizzard (ATVI), Lyft (LYFT), Match Group (MTCH), Devon Energy (DVN), Chesapeake Energy (CHK), Coursera (COUR), Zillow Group (ZG), Amgen (AMGN) after market close\nWednesday: Humana (HUM), Discovery Inc. (DISCA), The New York Times (NYT), Norwegian Cruise Line Holdings (NCLH), Marriott International (MAR), CVS Health Corp. (CVS), Sinclair Broadcast Group (SBGI) before market open; Booking Holdings (BKNG), Qorvo (QRVO), The Allstate Corp. (ALL), MGM Resorts International (MGM), $Take-Two Interactive Software(TTWO)$ (TTWO), Electronic Arts (EA), Vimeo (VMEO), Etsy (ETSY), GoDaddy (GDDY), Marathon Oil Corp. (MRO), Roku (ROKU), Qualcomm (QCOM) after market close\nThursday: Cigna (CI), Wayfair (W), ViacomCBS (VIAC), Nikola (NKLA), Duke Energy (DUK), Citrix Systems (CTXS), Regeneron Pharmaceuticals (REGN), Hanesbrands (HBI), Moderna (MRNA), Planet Fitness (PLNT), Vulcan Material (VMC), Kellogg (K), Square (SQ), Cloudflare (NET), Occidental Petroleum (OXY), Uber Technologies (UBER), American International Group (AIG), Shake Shack (SHAK), iHeartMedia (IHRT), Novavax (NVAX), IAC Interactive Corp. (IAC), Peloton (PTON), Dropbox (DBX), DataDog (DDOG), Pinterest (PINS), Skyworks Solutions (SWKS), Expedia (EXPE), Rocket Cos. (RKT), Live Nation Entertainment (LYV), Airbnb (ABNB)\nFriday: Wynn Resorts (WYNN), Dish Networks (DISH), Dominion Energy (D), DraftKings (DKNG), Goodyear Tire and Rubber (GT), Cinemark Holdings (CNK) before market open","news_type":1},"isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840981654,"gmtCreate":1635575212312,"gmtModify":1635575212411,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Up Tesla&nbsp;","listText":"Up Tesla&nbsp;","text":"Up Tesla","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840981654","repostId":"2179241322","repostType":4,"isVote":1,"tweetType":1,"viewCount":357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"hots":[{"id":849838403,"gmtCreate":1635740738541,"gmtModify":1635740738634,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/849838403","repostId":"2179250221","repostType":4,"repost":{"id":"2179250221","pubTimestamp":1635721559,"share":"https://www.laohu8.com/m/news/2179250221?lang=&edition=full","pubTime":"2021-11-01 07:05","market":"us","language":"en","title":"Federal Reserve decision, October jobs report: What to know this week","url":"https://stock-news.laohu8.com/highlight/detail?id=2179250221","media":"Yahoo Finance","summary":"The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set th","content":"<p><img src=\"https://static.tigerbbs.com/790c3fdfdc38fa2b5b3a13d89fb1959a\" tg-width=\"1878\" tg-height=\"2940\" width=\"100%\" height=\"auto\"></p>\n<p>The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also await more data on the U.S. economic recovery with the Labor Department's monthly jobs report later this week.</p>\n<p>The Federal Open Market Committee's (FOMC) November meeting will take place from Tuesday to Wednesday, with the policy statement and press conference from the meeting serving as the central bank's penultimate opportunity this year to announce formal plans to begin rolling back its crisis-era quantitative easing program. For the past year-and-a-half, the central bank has been purchasing $120 billion per month in agency mortgage-backed securities and Treasuries, as <a href=\"https://laohu8.com/S/AONE.U\">one</a> major tool to support the economy during the pandemic.</p>\n<p>In late September, the FOMC's latest monetary policy statement and press conference from Federal Reserve Chair Jerome <a href=\"https://laohu8.com/S/POWL\">Powell</a> suggested the central bank was apt to announce the start of tapering before year-end, and continue the tapering process until \"around the middle of next year.\"</p>\n<p>\"The upcoming FOMC meeting will be important for three reasons: 1) the announcement of tapering; 2) guidance around what tapering means for the path of hikes; and 3) nuanced changes in views around inflation risks given recent data,\" wrote <a href=\"https://laohu8.com/S/BAC\">Bank of America</a> economist Michelle Meyer in a note.</p>\n<p>\"The statement that announces the new pace of asset purchases will be followed by a note regarding flexibility stating that asset purchases are not on a pre-set course and will depend on the outlook for the labor market and inflation as well as an assessment of the efficacy of asset purchases,\" she predicted.</p>\n<p>She noted that Powell may also use the press conference to reiterate that the end of tapering would not necessarily indicate the start of rate hikes, and that both policy actions are distinct. In previous public remarks, Powell has already made a similar point in previous public remarks, saying, \"the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff.\"</p>\n<p>Given the market has been anticipating the start to tapering for months now, speculation around when the Fed will make a move on interest rates has become a point of particular interest to investors. <a href=\"https://laohu8.com/S/ISBC\">Investors</a> and economists have mulled whether the Fed may need to act more quickly than previously telegraphed on adjusting interest rates to stave off inflation, which has proven more long-lasting than some had suggested.</p>\n<p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/f0f0ae63a784eef5578397df02340483\" tg-width=\"4932\" tg-height=\"3288\" referrerpolicy=\"no-referrer\"><span>WASHINGTON, DC - SEPTEMBER 24: Federal Reserve Board Chairman Jerome Powell testifies during a Senate Banking Committee hearing on Capitol Hill on September 24, 2020 in Washington, DC. Powell and U.S. Treasury Secretary Steve Mnuchin are testifying about the CARES Act and the economic effects of the coronavirus pandemic. (Photo by Drew Angerer/Getty Images)Drew Angerer via Getty Images</span></p>\n<p>In September, core personal consumption expenditures — the Fed's preferred gauge of underlying inflation — rose 3.6% over last year for a fourth consecutive month, coming in at the fastest clip since 1991. And earlier this month, Powell acknowledged in public remarks that the supply chain constraints and shortages that spurred the latest rise in prices are \"likely to last longer than previously expected, likely well into next year.\"</p>\n<p>While the central bank will not release an updated Summary of Economic Projections with their policy statement on Wednesday, the latest projections from the September meeting suggested the committee was split on rate hikes for 2022, with nine members seeing no rate hikes by the end of next year while the other nine members saw at least <a href=\"https://laohu8.com/S/AONE.U\">one</a> hike.</p>\n<p>\"I think the Fed has pretty well determined to start the taper pretty quickly. We expect them to announce it next week and then start it soon thereafter, so that's pretty well carved in stone,\" Kathy Jones, <a href=\"https://laohu8.com/S/SCHW\">Charles Schwab</a> chief fixed income strategist, told Yahoo Finance Live last week. \"I think the big debate now is how quickly the Fed moves toward actually raising rates. The expectation in the market has really shifted to expecting as many as two rate hikes in 2022 and 2023 ... that’s a pretty aggressive pace of tightening.\"</p>\n<h2>October jobs report</h2>\n<p>One of this week's most closely watched pieces of economic data will be the October jobs report, which is due for release on Friday from the Labor Department.</p>\n<p>Economists are looking to see a pick-up in the pace of hiring for October after a disappointing print in September, when just 194,000 non-farm payrolls returned versus the half million expected. Over the past two months, payroll gains averaged at just 280,000. The unemployment rate is expected to take another small step toward pre-pandemic levels in October as well, with the jobless rate anticipated to dip to 4.7% from 4.8% the prior month.</p>\n<p>Still, the labor market has still fallen short its pre-pandemic conditions on a number of fronts. The unemployment rate has yet to return to its 50-year low of 3.5% from February 2020. And as of September, the civilian labor force was still down by about 3.1 million individuals from pre-virus levels.</p>\n<p>One factor weighing on the labor market in August and September was the Delta variant, which may have deterred some workers from seeking employment in person for risk of infection. And an ongoing element dragging on the labor market's recovery has been a mismatch of supply and demand, with employers struggling to fill a near-record number of job openings while voluntary quits jumped to a historically high level.</p>\n<p>\"Next week’s October payrolls report will shed light on whether supply eased on diminishing constraints or if the labor market continues to face headwinds for now,\" wrote Rubeela Farooqi, chief U.S. economist for High Frequency Economics, in a note last week.</p>\n<p>But some data from the past couple weeks has reflected favorably on conditions in the labor market in October. Weekly new unemployment claims broke below 300,000 for the first time since the start of the pandemic during the survey week for the October jobs report, or the week that includes the 12th of the month. And in the Conference Board's October Consumer Confidence Index, just 10.6% of consumers said jobs were \"hard to get,\" down from 13.0% in September. That brought the Conference Board's closely watched labor market differential, or percentage of consumers saying jobs are \"hard to get\" subtracted from the percentage saying jobs \"are plentiful,\" to 45, or its highest level since 2000.</p>\n<h2>Economic calendar</h2>\n<ul>\n <li><p><b>Monday: </b><a href=\"https://laohu8.com/S/MRKT\">Markit</a> U.S. Manufacturing PMI, Oct. final (59.3 expected, 59.2 in September); Constructing spending, month-over-month, September (0.4% expected, 0.0% in August); ISM Manufacturing Index, Oct. (60.5 expected, 61.1 in September)</p></li>\n <li><p><b>Tuesday: </b><i>No notable reports scheduled for release</i></p></li>\n <li><p><b>Wednesday: </b>MBA Mortgage Applications, week ended Oct. 29 (0.3% during prior week); ADP Employment Change, Oct. (400,000 expected, 568,000 in September); ISM Services Index, October (62.0 expected, 61.9 in September); Factory Orders, September (-0.1% expected, 1.2% in August); Durable goods orders, September final (-0.4% in prior print; Durable goods orders excluding transportation, September final (0.4% in prior print); Non-defense capital goods orders excluding aircraft, September final (0.8% in prior print); Markit U.S. Services PMI, October final (58.2 expected, 58.2 in prior print); Markit U.S. Composite PMI, October final (57.3 in prior print); Federal Open Market Committee monetary policy decision</p></li>\n <li><p><b>Thursday: </b>Challenger job cuts, year-over-year, October (-84.9% in September); Initial jobless claims, week ended Oct. 30 (275,000 expected, 281,000 during prior week); Continuing claims, week ended Oct. 23 (2.147 million expected, 2.243 million during prior week); Non-farm productivity, Q3 preliminary (-3.2% expected, 2.1% in <a href=\"https://laohu8.com/S/QTWO\">Q2</a>); <a href=\"https://laohu8.com/S/UNT\">Unit</a> Labor Costs, Q3 preliminary (6.9% expected, 1.3% in Q2); Trade balance, September (-$80.1 billion expected, -$73.3 billion in August)</p></li>\n <li><p><b>Friday: </b>Change in non-farm payrolls, October (450,000 expected, 194,000 in September); Unemployment rate, October (4.7% expected, 4.8% in September); Average hourly earnings, month-over-month, October (4.7% expected, 4.8% in September); Average hourly earnings, year-over-year, October (4.9% expected, 4.6% in September); Labor Force Participation Rate, October (61.8% expected, 61.6% in September); Consumer Credit, September ($16.200 billion expected, $14.379 million in August)</p></li>\n</ul>\n<h2>Earnings calendar</h2>\n<ul>\n <li><p><b>Monday: </b><a href=\"https://laohu8.com/S/CLX\">Clorox</a> (CLX), <a href=\"https://laohu8.com/S/CAR\">Avis Budget</a> Group (<a href=\"https://laohu8.com/S/00699\">CAR</a>), ZoomInfo Technologies (ZI), <a href=\"https://laohu8.com/S/CHGG\">Chegg Inc</a>. (CHGG), <a href=\"https://laohu8.com/S/FANG\">Diamondback Energy</a> (FANG), The <a href=\"https://laohu8.com/S/SPG\">Simon Property</a> Group (SPG) after market close</p></li>\n <li><p><b>Tuesday: </b><a href=\"https://laohu8.com/S/UA.C\">Under Armour</a> (UAA), <a href=\"https://laohu8.com/S/EL\">Estee Lauder</a> (EL), <a href=\"https://laohu8.com/S/RL\">Ralph Lauren</a> (RL), Apollo Global Management (APO), Corsair Gaming (CRSR), <a href=\"https://laohu8.com/S/BLMN\">Bloomin' Brands</a> (BLMN), <a href=\"https://laohu8.com/S/COP\">ConocoPhillips</a> (COP), <a href=\"https://laohu8.com/S/PFE\">Pfizer</a> (PFE), <a href=\"https://laohu8.com/S/GRPN\">Groupon</a> (GPN), <a href=\"https://laohu8.com/S/MPC\">Marathon</a> Petroleum (MPC) before market open; <a href=\"https://laohu8.com/S/MDLZ\">Mondelez</a> (MDLZ), T-Mobile (TMUS), <a href=\"https://laohu8.com/S/AKAM\">Akamai</a> (AKAM), <a href=\"https://laohu8.com/S/ATVI\">Activision Blizzard</a> (ATVI), Lyft (LYFT), <a href=\"https://laohu8.com/S/MTCH\">Match</a> Group (MTCH), <a href=\"https://laohu8.com/S/DVN\">Devon</a> Energy (DVN), <a href=\"https://laohu8.com/S/CHK\">Chesapeake</a> Energy (CHK), Coursera (COUR), <a href=\"https://laohu8.com/S/Z\">Zillow</a> Group (ZG), <a href=\"https://laohu8.com/S/AMGN\">Amgen</a> (AMGN) after market close</p></li>\n <li><p><b>Wednesday: </b><a href=\"https://laohu8.com/S/HUM\">Humana</a> (HUM), <a href=\"https://laohu8.com/S/DISCA\">Discovery</a> Inc. (DISCA), The <a href=\"https://laohu8.com/S/NYT\">New York Times</a> (NYT), <a href=\"https://laohu8.com/S/NCLH\">Norwegian Cruise Line</a> Holdings (NCLH), <a href=\"https://laohu8.com/S/MAR\">Marriott</a> International (MAR), <a href=\"https://laohu8.com/S/CVS\">CVS Health</a> Corp. (CVS), <a href=\"https://laohu8.com/S/SBGI\">Sinclair Broadcast Group</a> (SBGI) before market open; <a href=\"https://laohu8.com/S/BKNG\">Booking Holdings</a> (BKNG), <a href=\"https://laohu8.com/S/QRVO\">Qorvo</a> (QRVO), The <a href=\"https://laohu8.com/S/ALL\">Allstate</a> Corp. (ALL), <a href=\"https://laohu8.com/S/MGM\">MGM Resorts International</a> (MGM), $Take-<a href=\"https://laohu8.com/S/TWOA.U\">Two</a> Interactive Software(TTWO)$ (TTWO), <a href=\"https://laohu8.com/S/EA\">Electronic Arts</a> (EA), Vimeo (VMEO), <a href=\"https://laohu8.com/S/ETSY\">Etsy</a> (ETSY), <a href=\"https://laohu8.com/S/GDDY\">GoDaddy</a> (GDDY), <a href=\"https://laohu8.com/S/MRO\">Marathon</a> Oil Corp. (MRO), Roku (ROKU), <a href=\"https://laohu8.com/S/QCOM\">Qualcomm</a> (QCOM) after market close</p></li>\n <li><p><b>Thursday: </b><a href=\"https://laohu8.com/S/CI\">Cigna</a> (CI), <a href=\"https://laohu8.com/S/W\">Wayfair</a> (W), ViacomCBS (VIAC), Nikola (NKLA), <a href=\"https://laohu8.com/S/DEX.AU\">Duke</a> Energy (DUK), <a href=\"https://laohu8.com/S/CTXS\">Citrix</a> Systems (CTXS), <a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a> (REGN), <a href=\"https://laohu8.com/S/HBI\">Hanesbrands</a> (HBI), Moderna (MRNA), <a href=\"https://laohu8.com/S/PLNT\">Planet Fitness</a> (PLNT), Vulcan Material (VMC), <a href=\"https://laohu8.com/S/K\">Kellogg</a> (K), <a href=\"https://laohu8.com/S/SQ\">Square</a> (SQ), Cloudflare (NET), <a href=\"https://laohu8.com/S/OXY\">Occidental</a> Petroleum (OXY), <a href=\"https://laohu8.com/S/UBER\">Uber</a> Technologies (UBER), <a href=\"https://laohu8.com/S/AFG\">American</a> International Group (AIG), <a href=\"https://laohu8.com/S/SHAK\">Shake Shack</a> (SHAK), iHeartMedia (IHRT), <a href=\"https://laohu8.com/S/NVAX\">Novavax</a> (NVAX), IAC Interactive Corp. (IAC), Peloton (PTON), Dropbox (DBX), DataDog (DDOG), Pinterest (PINS), <a href=\"https://laohu8.com/S/SWKS\">Skyworks Solutions</a> (SWKS), <a href=\"https://laohu8.com/S/EXPE\">Expedia</a> (EXPE), Rocket Cos. (RKT), <a href=\"https://laohu8.com/S/LYV\">Live Nation Entertainment</a> (LYV), Airbnb (ABNB)</p></li>\n <li><p><b>Friday: </b><a href=\"https://laohu8.com/S/WYNN\">Wynn</a> Resorts (WYNN), Dish Networks (DISH), Dominion Energy (D), DraftKings (DKNG), <a href=\"https://laohu8.com/S/GT\">Goodyear</a> Tire and Rubber (GT), <a href=\"https://laohu8.com/S/CNK\">Cinemark</a> Holdings (CNK) before market open</p></li>\n</ul>","source":"yahoofinance_au","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Federal Reserve decision, October jobs report: What to know this week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFederal Reserve decision, October jobs report: What to know this week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 07:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html><strong>Yahoo Finance</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also ...</p>\n\n<a href=\"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"EL":"雅诗兰黛","RL":"拉夫劳伦","COP":"康菲石油","CRSR":"Corsair Gaming, Inc.",".DJI":"道琼斯","UBER":"优步","APO":"阿波罗全球管理","BLMN":"Bloomin' Brands","ATVI":"动视暴雪","PFE":"辉瑞",".IXIC":"NASDAQ Composite","CLX":"高乐氏",".SPX":"S&P 500 Index"},"source_url":"https://finance.yahoo.com/news/federal-reserve-meeting-october-jobs-report-what-to-know-this-week-151259921.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179250221","content_text":"The Federal Reserve's forthcoming monetary policy meeting will be in focus this week, and may set the stage for a long-awaited announcement of asset-purchase tapering. Meanwhile, traders will also await more data on the U.S. economic recovery with the Labor Department's monthly jobs report later this week.\nThe Federal Open Market Committee's (FOMC) November meeting will take place from Tuesday to Wednesday, with the policy statement and press conference from the meeting serving as the central bank's penultimate opportunity this year to announce formal plans to begin rolling back its crisis-era quantitative easing program. For the past year-and-a-half, the central bank has been purchasing $120 billion per month in agency mortgage-backed securities and Treasuries, as one major tool to support the economy during the pandemic.\nIn late September, the FOMC's latest monetary policy statement and press conference from Federal Reserve Chair Jerome Powell suggested the central bank was apt to announce the start of tapering before year-end, and continue the tapering process until \"around the middle of next year.\"\n\"The upcoming FOMC meeting will be important for three reasons: 1) the announcement of tapering; 2) guidance around what tapering means for the path of hikes; and 3) nuanced changes in views around inflation risks given recent data,\" wrote Bank of America economist Michelle Meyer in a note.\n\"The statement that announces the new pace of asset purchases will be followed by a note regarding flexibility stating that asset purchases are not on a pre-set course and will depend on the outlook for the labor market and inflation as well as an assessment of the efficacy of asset purchases,\" she predicted.\nShe noted that Powell may also use the press conference to reiterate that the end of tapering would not necessarily indicate the start of rate hikes, and that both policy actions are distinct. In previous public remarks, Powell has already made a similar point in previous public remarks, saying, \"the timing and pace of the coming reduction in asset purchases will not be intended to carry a direct signal regarding the timing of interest rate liftoff.\"\nGiven the market has been anticipating the start to tapering for months now, speculation around when the Fed will make a move on interest rates has become a point of particular interest to investors. Investors and economists have mulled whether the Fed may need to act more quickly than previously telegraphed on adjusting interest rates to stave off inflation, which has proven more long-lasting than some had suggested.\nWASHINGTON, DC - SEPTEMBER 24: Federal Reserve Board Chairman Jerome Powell testifies during a Senate Banking Committee hearing on Capitol Hill on September 24, 2020 in Washington, DC. Powell and U.S. Treasury Secretary Steve Mnuchin are testifying about the CARES Act and the economic effects of the coronavirus pandemic. (Photo by Drew Angerer/Getty Images)Drew Angerer via Getty Images\nIn September, core personal consumption expenditures — the Fed's preferred gauge of underlying inflation — rose 3.6% over last year for a fourth consecutive month, coming in at the fastest clip since 1991. And earlier this month, Powell acknowledged in public remarks that the supply chain constraints and shortages that spurred the latest rise in prices are \"likely to last longer than previously expected, likely well into next year.\"\nWhile the central bank will not release an updated Summary of Economic Projections with their policy statement on Wednesday, the latest projections from the September meeting suggested the committee was split on rate hikes for 2022, with nine members seeing no rate hikes by the end of next year while the other nine members saw at least one hike.\n\"I think the Fed has pretty well determined to start the taper pretty quickly. We expect them to announce it next week and then start it soon thereafter, so that's pretty well carved in stone,\" Kathy Jones, Charles Schwab chief fixed income strategist, told Yahoo Finance Live last week. \"I think the big debate now is how quickly the Fed moves toward actually raising rates. The expectation in the market has really shifted to expecting as many as two rate hikes in 2022 and 2023 ... that’s a pretty aggressive pace of tightening.\"\nOctober jobs report\nOne of this week's most closely watched pieces of economic data will be the October jobs report, which is due for release on Friday from the Labor Department.\nEconomists are looking to see a pick-up in the pace of hiring for October after a disappointing print in September, when just 194,000 non-farm payrolls returned versus the half million expected. Over the past two months, payroll gains averaged at just 280,000. The unemployment rate is expected to take another small step toward pre-pandemic levels in October as well, with the jobless rate anticipated to dip to 4.7% from 4.8% the prior month.\nStill, the labor market has still fallen short its pre-pandemic conditions on a number of fronts. The unemployment rate has yet to return to its 50-year low of 3.5% from February 2020. And as of September, the civilian labor force was still down by about 3.1 million individuals from pre-virus levels.\nOne factor weighing on the labor market in August and September was the Delta variant, which may have deterred some workers from seeking employment in person for risk of infection. And an ongoing element dragging on the labor market's recovery has been a mismatch of supply and demand, with employers struggling to fill a near-record number of job openings while voluntary quits jumped to a historically high level.\n\"Next week’s October payrolls report will shed light on whether supply eased on diminishing constraints or if the labor market continues to face headwinds for now,\" wrote Rubeela Farooqi, chief U.S. economist for High Frequency Economics, in a note last week.\nBut some data from the past couple weeks has reflected favorably on conditions in the labor market in October. Weekly new unemployment claims broke below 300,000 for the first time since the start of the pandemic during the survey week for the October jobs report, or the week that includes the 12th of the month. And in the Conference Board's October Consumer Confidence Index, just 10.6% of consumers said jobs were \"hard to get,\" down from 13.0% in September. That brought the Conference Board's closely watched labor market differential, or percentage of consumers saying jobs are \"hard to get\" subtracted from the percentage saying jobs \"are plentiful,\" to 45, or its highest level since 2000.\nEconomic calendar\n\nMonday: Markit U.S. Manufacturing PMI, Oct. final (59.3 expected, 59.2 in September); Constructing spending, month-over-month, September (0.4% expected, 0.0% in August); ISM Manufacturing Index, Oct. (60.5 expected, 61.1 in September)\nTuesday: No notable reports scheduled for release\nWednesday: MBA Mortgage Applications, week ended Oct. 29 (0.3% during prior week); ADP Employment Change, Oct. (400,000 expected, 568,000 in September); ISM Services Index, October (62.0 expected, 61.9 in September); Factory Orders, September (-0.1% expected, 1.2% in August); Durable goods orders, September final (-0.4% in prior print; Durable goods orders excluding transportation, September final (0.4% in prior print); Non-defense capital goods orders excluding aircraft, September final (0.8% in prior print); Markit U.S. Services PMI, October final (58.2 expected, 58.2 in prior print); Markit U.S. Composite PMI, October final (57.3 in prior print); Federal Open Market Committee monetary policy decision\nThursday: Challenger job cuts, year-over-year, October (-84.9% in September); Initial jobless claims, week ended Oct. 30 (275,000 expected, 281,000 during prior week); Continuing claims, week ended Oct. 23 (2.147 million expected, 2.243 million during prior week); Non-farm productivity, Q3 preliminary (-3.2% expected, 2.1% in Q2); Unit Labor Costs, Q3 preliminary (6.9% expected, 1.3% in Q2); Trade balance, September (-$80.1 billion expected, -$73.3 billion in August)\nFriday: Change in non-farm payrolls, October (450,000 expected, 194,000 in September); Unemployment rate, October (4.7% expected, 4.8% in September); Average hourly earnings, month-over-month, October (4.7% expected, 4.8% in September); Average hourly earnings, year-over-year, October (4.9% expected, 4.6% in September); Labor Force Participation Rate, October (61.8% expected, 61.6% in September); Consumer Credit, September ($16.200 billion expected, $14.379 million in August)\n\nEarnings calendar\n\nMonday: Clorox (CLX), Avis Budget Group (CAR), ZoomInfo Technologies (ZI), Chegg Inc. (CHGG), Diamondback Energy (FANG), The Simon Property Group (SPG) after market close\nTuesday: Under Armour (UAA), Estee Lauder (EL), Ralph Lauren (RL), Apollo Global Management (APO), Corsair Gaming (CRSR), Bloomin' Brands (BLMN), ConocoPhillips (COP), Pfizer (PFE), Groupon (GPN), Marathon Petroleum (MPC) before market open; Mondelez (MDLZ), T-Mobile (TMUS), Akamai (AKAM), Activision Blizzard (ATVI), Lyft (LYFT), Match Group (MTCH), Devon Energy (DVN), Chesapeake Energy (CHK), Coursera (COUR), Zillow Group (ZG), Amgen (AMGN) after market close\nWednesday: Humana (HUM), Discovery Inc. (DISCA), The New York Times (NYT), Norwegian Cruise Line Holdings (NCLH), Marriott International (MAR), CVS Health Corp. (CVS), Sinclair Broadcast Group (SBGI) before market open; Booking Holdings (BKNG), Qorvo (QRVO), The Allstate Corp. (ALL), MGM Resorts International (MGM), $Take-Two Interactive Software(TTWO)$ (TTWO), Electronic Arts (EA), Vimeo (VMEO), Etsy (ETSY), GoDaddy (GDDY), Marathon Oil Corp. (MRO), Roku (ROKU), Qualcomm (QCOM) after market close\nThursday: Cigna (CI), Wayfair (W), ViacomCBS (VIAC), Nikola (NKLA), Duke Energy (DUK), Citrix Systems (CTXS), Regeneron Pharmaceuticals (REGN), Hanesbrands (HBI), Moderna (MRNA), Planet Fitness (PLNT), Vulcan Material (VMC), Kellogg (K), Square (SQ), Cloudflare (NET), Occidental Petroleum (OXY), Uber Technologies (UBER), American International Group (AIG), Shake Shack (SHAK), iHeartMedia (IHRT), Novavax (NVAX), IAC Interactive Corp. (IAC), Peloton (PTON), Dropbox (DBX), DataDog (DDOG), Pinterest (PINS), Skyworks Solutions (SWKS), Expedia (EXPE), Rocket Cos. (RKT), Live Nation Entertainment (LYV), Airbnb (ABNB)\nFriday: Wynn Resorts (WYNN), Dish Networks (DISH), Dominion Energy (D), DraftKings (DKNG), Goodyear Tire and Rubber (GT), Cinemark Holdings (CNK) before market open","news_type":1},"isVote":1,"tweetType":1,"viewCount":201,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":690874632,"gmtCreate":1639659855187,"gmtModify":1639659855348,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay 👌&nbsp;","listText":"Okay 👌&nbsp;","text":"Okay 👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/690874632","repostId":"1142996286","repostType":4,"repost":{"id":"1142996286","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639659703,"share":"https://www.laohu8.com/m/news/1142996286?lang=&edition=full","pubTime":"2021-12-16 21:01","market":"us","language":"en","title":"Toplines Before US Market Open on Thursday","url":"https://stock-news.laohu8.com/highlight/detail?id=1142996286","media":"Tiger Newspress","summary":"U.S. stock-index futures advanced Thursday morning after the market staged a U-turn the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.$Delta Air Lines$ – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-","content":"<p>U.S.&nbsp;stock-index futures advanced Thursday morning after&nbsp;the market staged a U-turn&nbsp;the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&amp;P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.<img src=\"https://static.tigerbbs.com/6e8a71c62338c2a045263d40bb9c86e4\" tg-width=\"1080\" tg-height=\"368\" width=\"100%\" height=\"auto\">With the Fed giving markets a breather Wednesday, traders will turn their Thursday to&nbsp;fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after&nbsp;last’s 52-week low.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/DAL\">Delta Air Lines</a></b> – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.</p>\n<p><b><a href=\"https://laohu8.com/S/ACN\">Accenture PLC</a></b> – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.</p>\n<p><b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.</p>\n<p><b><a href=\"https://laohu8.com/S/LEN\">Lennar</a></b> – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.</p>\n<p><b><a href=\"https://laohu8.com/S/NVS\">Novartis AG</a></b> – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/V\">Visa</a>&nbsp;</b>– <a href=\"https://laohu8.com/S/V\">Visa</a> rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.</p>\n<p><b><a href=\"https://laohu8.com/S/SJM\">Smucker's</a> </b>– Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.</p>\n<p><b><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> </b>– <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/T\">AT&amp;T Inc</a> </b>– Morgan Stanley upgraded AT&amp;T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&amp;T gained 1.5% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> </b>– The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.</p>\n<p><b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a> </b>– The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Toplines Before US Market Open on Thursday</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nToplines Before US Market Open on Thursday\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-12-16 21:01</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>U.S.&nbsp;stock-index futures advanced Thursday morning after&nbsp;the market staged a U-turn&nbsp;the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.</p>\n<p>At 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&amp;P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.<img src=\"https://static.tigerbbs.com/6e8a71c62338c2a045263d40bb9c86e4\" tg-width=\"1080\" tg-height=\"368\" width=\"100%\" height=\"auto\">With the Fed giving markets a breather Wednesday, traders will turn their Thursday to&nbsp;fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after&nbsp;last’s 52-week low.</p>\n<p><b>Stocks making the biggest moves premarket: </b></p>\n<p><b><a href=\"https://laohu8.com/S/DAL\">Delta Air Lines</a></b> – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.</p>\n<p><b><a href=\"https://laohu8.com/S/ACN\">Accenture PLC</a></b> – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.</p>\n<p><b><a href=\"https://laohu8.com/S/REGN\">Regeneron Pharmaceuticals</a></b> – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.</p>\n<p><b><a href=\"https://laohu8.com/S/LEN\">Lennar</a></b> – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.</p>\n<p><b><a href=\"https://laohu8.com/S/NVS\">Novartis AG</a></b> – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/V\">Visa</a>&nbsp;</b>– <a href=\"https://laohu8.com/S/V\">Visa</a> rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.</p>\n<p><b><a href=\"https://laohu8.com/S/SJM\">Smucker's</a> </b>– Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.</p>\n<p><b><a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> </b>– <a href=\"https://laohu8.com/S/ISRG\">Intuitive Surgical</a> was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.</p>\n<p><b><a href=\"https://laohu8.com/S/T\">AT&amp;T Inc</a> </b>– Morgan Stanley upgraded AT&amp;T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&amp;T gained 1.5% in premarket trading.</p>\n<p><b><a href=\"https://laohu8.com/S/WOOF\">Petco Health and Wellness Company, Inc.</a> </b>– The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.</p>\n<p><b><a href=\"https://laohu8.com/S/SHOP\">Shopify</a> </b>– The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1142996286","content_text":"U.S. stock-index futures advanced Thursday morning after the market staged a U-turn the previous trading session, welcoming a Federal Reserve decision to ramp up the pace of its taper and leave interest rates unchanged — for now.\nAt 8:00 a.m. ET, Dow e-minis were up 204 points, or 0.57%, S&P 500 e-minis were up 31.25 points, or 0.66%, and Nasdaq 100 e-minis were up 115.25 points, or 0.71%.With the Fed giving markets a breather Wednesday, traders will turn their Thursday to fresh Labor Department data on initial weekly jobless claims. First-time unemployment filings are expected to reflect a slight increase after last’s 52-week low.\nStocks making the biggest moves premarket: \nDelta Air Lines – Delta rose 2.3% in the premarket after projecting a $200 million fourth-quarter profit. Consensus forecasts were predicting a quarterly loss for Delta, but the carrier said it is seeing strong holiday demand and it is on the path toward exceeding pre-pandemic profit levels.\nAccenture PLC – The consulting firm’s shares surged 6.7% in the premarket after it reported better-than-expected profit and revenue for its latest quarter, and raised its earnings guidance for fiscal 2022. Revenue rose by more than 20% across the four biggest industry groups in Accenture’s customer base.\nRegeneron Pharmaceuticals – The drugmaker’s shares declined 1% in premarket trading after it said its antibody cocktail loses potency against the omicron Covid-19 variant. Regeneron did say that the cocktail is effective against the delta variant.\nLennar – Lennar reported quarterly earnings of $3.91 per share, below the $4.15 consensus estimate, and the homebuilder’s revenue also fell short of forecasts. Lennar was hurt by higher lumber costs as well as increased labor costs and shortages of raw materials, resulting in delayed home deliveries. Lennar tumbled 6.3% in premarket action.\nNovartis AG – Novartis launched a new share buyback program worth up to $15 billion, with the drug maker planning to complete those repurchases by the end of 2023. Shares jumped 4% in premarket trading.\nVisa – Visa rose 1.1% in the premarket after announcing that it added $12 billion to its share buyback program, bringing the total amount of its repurchase authority to $13.2 billion.\nSmucker's – Smucker struck a deal to sell its natural beverage and grains businesses to private equity firm Nexus Capital Management for $110 million, with the food producer saying it wanted to focus more resources on its core brands.\nIntuitive Surgical – Intuitive Surgical was added to the “conviction buy” list at Goldman Sachs, which points to the company’s pending launch of a new surgical system. Shares added 1.2% in the premarket.\nAT&T Inc – Morgan Stanley upgraded AT&T to “overweight” from “equal-weight,” saying a recent slide by the stock creates an attractive risk-reward profile. The firm said there are several other key factors driving the upgrade, including the pending completion of the WarnerMedia/Discoverymerger. AT&T gained 1.5% in premarket trading.\nPetco Health and Wellness Company, Inc. – The pet products seller’s stock added 1.9% in the premarket after Needham began coverage with a “buy” rating. The firm feels Petco should outperform competitors in the pet category, given its presence in multiple channels including veterinary hospitals.\nShopify – The e-commerce platform operator rallied 2.9% in premarket trading after Evercore upgraded it to “outperform” from “in line.” Evercore noted that the stock is about 20% below its year highs and that the company represents a high-quality asset in terms of growth opportunities.","news_type":1},"isVote":1,"tweetType":1,"viewCount":396,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872777574,"gmtCreate":1637582901485,"gmtModify":1637582901485,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👍&nbsp;","listText":"👍&nbsp;","text":"👍","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872777574","repostId":"1171692239","repostType":4,"repost":{"id":"1171692239","pubTimestamp":1637582731,"share":"https://www.laohu8.com/m/news/1171692239?lang=&edition=full","pubTime":"2021-11-22 20:05","market":"us","language":"en","title":"Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development","url":"https://stock-news.laohu8.com/highlight/detail?id=1171692239","media":"Reuters","summary":"BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its ","content":"<p>BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.</p>\n<p>Sanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more</p>\n<p>Sanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.</p>\n<p>The French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.</p>\n<p>Baidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.</p>\n<p>\"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.</p>\n<p>An mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.</p>\n<p>Baidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.</p>\n<p>Specifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to&nbsp;lab studies and animal tests, which haven't gone through peer-review.</p>","source":"lsy1601381805984","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Baidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBaidu in partnership with Sanofi to use its algorithm in mRNA vaccine, therapy development\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-22 20:05 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/><strong>Reuters</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and ...</p>\n\n<a href=\"https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SNYNF":"Sanofi","BIDU":"百度","09888":"百度集团-SW"},"source_url":"https://www.reuters.com/markets/europe/baidu-partnership-with-sanofi-use-its-algorithm-mrna-vaccine-therapy-development-2021-11-22/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1171692239","content_text":"BEIJING, Nov 22 (Reuters) - Chinese tech giant Baidu Inc(9888.HK)said on Monday it has licensed its algorithm for messenger RNA (mRNA) sequence to Sanofi SA for use in designing vaccine and therapeutic products, entering its first such commercial deal with a major global drugmaker.\nSanofi(SASY.PA)had been one of the world's biggest vaccine makers before the pandemic, but the French firm was beaten by rivals BioNTech /Pfizer(PFE.N)and Moderna(MRNA.O)in developing mRNA shots against COVID-19.read more\nSanofi stopped trials of its own mRNA COVID-19 shot in September, and is instead focusing on efforts with GlaxoSmithKline(GSK.L)to bring another COVID-19 vaccine candidate to market based on the more conventional protein-based approach.\nThe French groupsaidit would focus its mRNA resources on other infectious diseases and therapeutics with strong unmet need.\nBaidu will receive milestone payments when any mRNA-based therapy or vaccine candidate discovered by Sanofi using its algorithm enters clinical trials, said Huang Liang, a Baidu scientist leading the project.\n\"The fact that this agreement includes milestone payments shows that [Sanofi] has great confidence in bringing candidates developed with Baidu algorithm into clinical trials and to the market,\" Huang told Reuters. He declined to disclose the size of the deal.\nAn mRNA-based vaccine contains mRNA sequence which instructs human cells to produce proteins that can spur the immune system into action.\nBaidu's algorithm is designed to deliver a larger number of optimised mRNA sequences and there are early signs that it could be more suitable than standard algorithms in vaccine and therapeutic drug development, Huang said.\nSpecifically regarding COVID-19 vaccine candidates, those containing mRNA sequences generated by Baidu's algorithm were more stable and appeared to require a smaller dosage than a baseline shot based on a standard algorithm, according to lab studies and animal tests, which haven't gone through peer-review.","news_type":1},"isVote":1,"tweetType":1,"viewCount":631,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841634688,"gmtCreate":1635905542092,"gmtModify":1635905542092,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":1,"repostSize":0,"link":"https://laohu8.com/post/841634688","repostId":"2180736486","repostType":4,"isVote":1,"tweetType":1,"viewCount":82,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":608178636,"gmtCreate":1638672598165,"gmtModify":1638672598165,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/608178636","repostId":"2188057871","repostType":4,"repost":{"id":"2188057871","weMediaInfo":{"introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"media_name":"Dow Jones","id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"pubTimestamp":1638580800,"share":"https://www.laohu8.com/m/news/2188057871?lang=&edition=full","pubTime":"2021-12-04 09:20","market":"us","language":"en","title":"Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2188057871","media":"Dow Jones","summary":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic bo","content":"<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Adobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAdobe worth $26 billion less as DocuSign fears spark 'knee-jerk reaction' for stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time\">2021-12-04 09:20</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Adobe stock was the worst performer in S&amp;P 500 Friday, after e-signature rival suggested pandemic boom was slowing down</p>\n<p>Shares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.</p>\n<p>DocuSign <a href=\"https://laohu8.com/S/DOCU\">$(DOCU)$</a> Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.</p>\n<p>Some of that investor fear seemed to transfer over to Adobe <a href=\"https://laohu8.com/S/ADBE\">$(ADBE)$</a>, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&amp;P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.</p>\n<p>The decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"</p>\n<p>\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.</p>\n<p>Adobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"</p>\n<p>While other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.</p>\n<p>Adobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.</p>\n<p>Shares of Adobe were up 86% since March 2020 as of Thursday's close.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"BK4527":"明星科技股","BK4567":"ESG概念","ADBE":"Adobe","BK4534":"瑞士信贷持仓","BK4528":"SaaS概念","BK4533":"AQR资本管理(全球第二大对冲基金)","BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4566":"资本集团","DOCU":"Docusign"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2188057871","content_text":"Adobe stock was the worst performer in S&P 500 Friday, after e-signature rival suggested pandemic boom was slowing down\nShares of Adobe Inc. sank to their worst performance in more than 20 months Friday, after DocuSign Inc. delivered what some saw as a the latest sign of a demand cool-down for work-from-home software.\nDocuSign $(DOCU)$ Chief Executive Dan Springer acknowledged Thursday that while his electronic-signature company saw \"accelerated growth\" for six quarters amid the pandemic, customers have gone back to \"more normalized buying patterns.\" As a result, DocuSign delivered a downbeat bookings outlook, sending its shares cratering more than 40%.\nSome of that investor fear seemed to transfer over to Adobe $(ADBE)$, which also offers contract-management software and allows for the collection of e-signatures. Adobe's stock fell 8.2% Friday, its steepest single-day percentage drop since March 2020 and the worst performance on the day from an S&P 500 stock. The move wiped away $26.3 billion in market capitalization, taking Adobe's valuation lower than $300 billion.\nThe decline in Adobe shares struck Wedbush analyst Daniel Ives as a \"DOCU-related selloff,\" he told MarketWatch, as DocuSign's report served as a \"a barometer that the WFH tailwinds are now abating and could be a headwind for Adobe.\"\n\"The DOCU print was a shocker and this is a knee-jerk reaction,\" he said.\nAdobe is due to post its own quarterly results Dec. 16. The company highlighted its e-signature technology in its prior earnings report, as Chief Financial Officer John Murphy noted that \"third-quarter Document Cloud growth drivers included adoption of Sign in Acrobat driven by the increased need to collaborate in a hybrid work environment.\"\nWhile other at-home stocks took a hit on disappointing outlooks earlier in the course of the pandemic, DocuSign initially appeared more resilient. Its stock hit an all-time high in September and was up 165% since March 2020 as of Thursday's close. Now the company will need to \"show that it can generate, not just fulfill, demand on a regular basis,\" according to an Evercore analyst.\nAdobe has a more diversified business than DocuSign. While the company sells contract-related software, it has a variety of other offerings including subscriptions to creative programs like Photoshop. Adobe's Document Cloud accounted for about 13% of the company's overall revenue in its last-reported quarter.\nShares of Adobe were up 86% since March 2020 as of Thursday's close.","news_type":1},"isVote":1,"tweetType":1,"viewCount":564,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878532155,"gmtCreate":1637204802922,"gmtModify":1637204802922,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878532155","repostId":"1161909759","repostType":4,"repost":{"id":"1161909759","pubTimestamp":1637203262,"share":"https://www.laohu8.com/m/news/1161909759?lang=&edition=full","pubTime":"2021-11-18 10:41","market":"us","language":"en","title":"Cassava Sciences Stock Tumbles on News of SEC Investigation","url":"https://stock-news.laohu8.com/highlight/detail?id=1161909759","media":"The Street","summary":"The biotech faces claims of manipulating research results of its Alzheimer’s drug.\n$Cassava Sciences","content":"<p>The biotech faces claims of manipulating research results of its Alzheimer’s drug.</p>\n<p>$Cassava Sciences&nbsp;(<b>SAVA</b>)$&nbsp;plummeted Wednesday after disclosing that \"certain government agencies\", which reportedly included&nbsp;the Securities and Exchange Commission, were investing claims the biotech&nbsp;manipulated research results of its experimental Alzheimer’s drug,&nbsp;simufilam.</p>\n<p>Shares of the Austin, Texas company were&nbsp;down more&nbsp;than 23% to $47.07&nbsp;Wednesday.</p>\n<p><img src=\"https://static.tigerbbs.com/ba12f81714da2c89bed996a8439c131d\" tg-width=\"882\" tg-height=\"624\" referrerpolicy=\"no-referrer\"></p>\n<p>Cassava said in a securities filing that \"certain government agencies have asked us to provide them with corporate information and documents\" and the Wall Street Journal, citing people familiar with the matter, that the agency was the SEC.</p>\n<p>\"We have been cooperating and will continue to cooperate with government authorities,\" Cassava said it is filing. \"No government agency has informed us that any wrongdoing has occurred by any party.\"</p>\n<p>The National Institutes of Health, which awarded $20 million in grants to Cassava and its academic collaborators since 2015 for drug development, is also examining the claims, according to the company’s chief executive officer.</p>\n<p>Cassava Sciences becameembroiled in controversyin August when Jordan Thomas, a partner and chair of the whistleblower representation practice at Labaton Sucharow, filed a citizen's petition with the U.S. Food and Drug Administration seeking to&nbsp;halt to trials of simufilam.</p>\n<p>On Wednesday, Thomas wrote a letter to acting U.S. Food and Drug Administration Janet Woodcock saying \"my clients’ worst fears about Cassava Sciences appear to have been true.\"</p>\n<p>Thomas identified his clients as&nbsp;David Bredt, former neuroscience research chief at Johnson &amp; Johnson&nbsp;(<b>JNJ</b>) Report&nbsp;and Eli Lilly &amp; Co.&nbsp;(<b>LLY</b>) , and Geoffrey Pitt, a cardiologist and professor at Weill Cornell Medicine</p>\n<p>\"Due to their serious concerns about simufilam and related research by Cassava,\" Thomas said, \"and at great personal and professional risk, my whistleblower clients, along with other prominent doctors and scientists, have voluntarily gone on the record.\"</p>\n<p>Bredt and Pitt wrote that Cassava’s research include images of experiments that appear to have been manipulated using software such as Photoshop.</p>\n<p>Thomas said that \"increasingly evidence suggests that Cassava has doctored its research and clinical trial results, duped peer-reviewed journals, used the tainted science to trick the NIH and FDA into approving grants and clinical trials.\"</p>\n<p>In addition, the company \"misled investors by touting their grants and clinical trials without disclosing their troubling research practices, and withheld material information about the true nature of its drug from vulnerable Alzheimer’s Disease patients.\"</p>\n<p>The FDA has a duty, Thomas said,&nbsp;\"to immediately halt the simufilam clinical trials, conduct a rigorous audit of all the company’s research and clinical trial results, and report the agency’s findings to interested law enforcement and regulatory authorities.\"</p>\n<p>Cassava did not immediately respond to a request for comment, but Chief Executive Remi Barbier has said that short sellers have abused the FDA’s petition process.</p>","source":"lsy1610613172068","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Cassava Sciences Stock Tumbles on News of SEC Investigation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nCassava Sciences Stock Tumbles on News of SEC Investigation\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 10:41 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.thestreet.com/investing/cassava-sciences-stock-tumbles-on-news-of-sec-investigation><strong>The Street</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The biotech faces claims of manipulating research results of its Alzheimer’s drug.\n$Cassava Sciences (SAVA)$ plummeted Wednesday after disclosing that \"certain government agencies\", which reportedly ...</p>\n\n<a href=\"https://www.thestreet.com/investing/cassava-sciences-stock-tumbles-on-news-of-sec-investigation\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SAVA":"Cassava Sciences Inc"},"source_url":"https://www.thestreet.com/investing/cassava-sciences-stock-tumbles-on-news-of-sec-investigation","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1161909759","content_text":"The biotech faces claims of manipulating research results of its Alzheimer’s drug.\n$Cassava Sciences (SAVA)$ plummeted Wednesday after disclosing that \"certain government agencies\", which reportedly included the Securities and Exchange Commission, were investing claims the biotech manipulated research results of its experimental Alzheimer’s drug, simufilam.\nShares of the Austin, Texas company were down more than 23% to $47.07 Wednesday.\n\nCassava said in a securities filing that \"certain government agencies have asked us to provide them with corporate information and documents\" and the Wall Street Journal, citing people familiar with the matter, that the agency was the SEC.\n\"We have been cooperating and will continue to cooperate with government authorities,\" Cassava said it is filing. \"No government agency has informed us that any wrongdoing has occurred by any party.\"\nThe National Institutes of Health, which awarded $20 million in grants to Cassava and its academic collaborators since 2015 for drug development, is also examining the claims, according to the company’s chief executive officer.\nCassava Sciences becameembroiled in controversyin August when Jordan Thomas, a partner and chair of the whistleblower representation practice at Labaton Sucharow, filed a citizen's petition with the U.S. Food and Drug Administration seeking to halt to trials of simufilam.\nOn Wednesday, Thomas wrote a letter to acting U.S. Food and Drug Administration Janet Woodcock saying \"my clients’ worst fears about Cassava Sciences appear to have been true.\"\nThomas identified his clients as David Bredt, former neuroscience research chief at Johnson & Johnson (JNJ) Report and Eli Lilly & Co. (LLY) , and Geoffrey Pitt, a cardiologist and professor at Weill Cornell Medicine\n\"Due to their serious concerns about simufilam and related research by Cassava,\" Thomas said, \"and at great personal and professional risk, my whistleblower clients, along with other prominent doctors and scientists, have voluntarily gone on the record.\"\nBredt and Pitt wrote that Cassava’s research include images of experiments that appear to have been manipulated using software such as Photoshop.\nThomas said that \"increasingly evidence suggests that Cassava has doctored its research and clinical trial results, duped peer-reviewed journals, used the tainted science to trick the NIH and FDA into approving grants and clinical trials.\"\nIn addition, the company \"misled investors by touting their grants and clinical trials without disclosing their troubling research practices, and withheld material information about the true nature of its drug from vulnerable Alzheimer’s Disease patients.\"\nThe FDA has a duty, Thomas said, \"to immediately halt the simufilam clinical trials, conduct a rigorous audit of all the company’s research and clinical trial results, and report the agency’s findings to interested law enforcement and regulatory authorities.\"\nCassava did not immediately respond to a request for comment, but Chief Executive Remi Barbier has said that short sellers have abused the FDA’s petition process.","news_type":1},"isVote":1,"tweetType":1,"viewCount":151,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":841619557,"gmtCreate":1635905743400,"gmtModify":1635905743400,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/841619557","repostId":"1186977790","repostType":4,"repost":{"id":"1186977790","pubTimestamp":1635905359,"share":"https://www.laohu8.com/m/news/1186977790?lang=&edition=full","pubTime":"2021-11-03 10:09","market":"us","language":"en","title":"KFC Wanted to ‘Beat Us Down,’ Pilgrim’s Pride Witness Says","url":"https://stock-news.laohu8.com/highlight/detail?id=1186977790","media":"Bloomberg","summary":"KFC Corp.’s top price negotiator told executives for Pilgrim’s Pride Corp. in 2017 that “he was goin","content":"<p>KFC Corp.’s top price negotiator told executives for Pilgrim’s Pride Corp. in 2017 that “he was going to beat us down with a hammer and a baseball bat” as payback for three years of high chicken prices. That’s according to the government’s star witness in the trial of 10 chicken-industry workers and executives charged with criminal price-fixing.</p>\n<p>Robert Bryant, a longtime Pilgrim’s Pride employee currently on leave, testified in Denver about talks between Pilgrim’s, the No. 2 U.S. chicken producer, and the company that manages supply for Yum! Brands Inc.’s KFC, Pizza Hut and Taco Bell fast-food restaurants. The KFC negotiator, Pete Suerken, was working on a new contract with Pilgrim’s after a three-year deal that included unprecedented price increases, according to Bryant, who took the stand Monday and Tuesday.</p>\n<p>At the heart of the matter is whether the defendants conspired to inflate prices in the $95 billion U.S. market. During opening remarks last week, Justice Department lawyer Michael Koenig said the insiders, who worked for competing chicken companies including top producer Tyson Foods Inc., came together to create “massive, historic price increases” and stonewalled efforts by customers including KFC to negotiate them lower.</p>\n<p>The defendants, who include former Pilgrim’s chief executives Jayson Penn and William Lovette, have all pleaded not guilty and are fighting the charges in the trial. They claim there was no conspiracy to fix prices or rig bids. Efforts to discover details of competitors’ prices were legal and chicken prices were the result of market forces, not illegal collusion, they said.</p>\n<p>Bryant is taking the stand with immunity as a result of a Pilgrim’s plea deal, and his testimony has been hotly anticipated as key to the government’s case. On cross-examination, Bryant admitted that he had lied to the FBI “multiple times” on matters unrelated to the price-fixing investigation. The subject of Bryant’s lies wasn’t made public.</p>\n<p>‘Two-Way Street’</p>\n<p>Bryant on Monday coolly pointed out for jurors the former colleagues and industry contacts who face charges that could land them in prison and bring million-dollar fines. He said Pilgrim’s and its competitors routinely shared information about pricing and planned bids “to increase prices or to limit a decrease, depending on the market conditions.”</p>\n<p>“My understanding is it was a two-way street,” Bryant told jurors. “We received their prices and they received ours.”</p>\n<p>He testified that the goal in 2014 was to raise prices. In 2017, the aim was to limit the damage at a time when prices were declining. KFC that year forced Pilgrim’s Pride to reduce prices and decreased the company’s volume, in retaliation for the earlier contract.</p>\n<p>“He was upset about 2014,” Bryant said.</p>\n<p>Prosecutors showed jurors Bryant’s handwritten notes from 2017 showing what he testified were planned bids by five Pilgrim’s competitors, including Tyson. Suppliers bid every year on contracts with the biggest fast-food companies, including KFC, Chick-fil-A Inc. and Popeyes Louisiana Kitchen Inc. The contracts help set the business prospects for the companies as well as the prices paid by people who eat chicken.</p>\n<p>‘Pandemic Profiteering’</p>\n<p>Bryant conceded, under cross-examination by lawyer Michael Feldberg, that the numbers in his notes didn’t match the actual prices that were later charged by the companies. Feldberg pressed Bryant to acknowledge market influences on chicken prices, including severe shortages in 2014. And he suggested Bryant is lying about an agreement among the defendants to fix prices to curry favor with the government and avoid facing criminal charges himself.</p>\n<p>While the evidence covers alleged efforts to fix prices and rig bids from 2012 to early 2019, the findings could set the stage for further moves against the industry, which has caught the ire of the Biden administration. Officials have said meatpackers engaged in “pandemic profiteering,” squeezing consumers and farmers.</p>\n<p>Greeley, Colorado-based Pilgrim’s Pride, a unit of Brazilian food giant JBS SA, pleaded guilty to price-fixing conspiracy in February and was sentenced to pay $108 million in fines. As part of the plea deal, Pilgrim’s agreed to cooperate with the government investigation. In a statement last week, the company said it is “focused on maintaining our commitment to fair and honest competition in compliance with U.S. antitrust laws.”</p>\n<p>Tyson last year said it was cooperating with the Justice Department.</p>\n<p>10 Defendants</p>\n<p>In addition to Penn and Lovette, prosecutors charged Roger Austin, a former vice president of Pilgrim’s; Mikell Fries, president of Claxton Poultry Farms Inc.; Scott Brady, a Claxton vice president; Timothy Mulrenin, a Perdue Farms Inc. executive who previously worked at Tyson; William Kantola, a Koch Foods Inc. sales executive; Jimmie Lee Little, a former Pilgrim’s Pride sales director; Gary Brian Roberts, a Case Farms Inc. employee who had previously worked at Tyson; and Rickie Blake, a former director and manager at George’s Inc.</p>\n<p>All are charged with violating the Sherman Act, a law that dates to 1890 and is intended to preserve competition in U.S. markets. Each defendant is charged with a single count of conspiracy to restrain trade, which carries a maximum of 10 years in prison. Little is also charged with obstruction of justice, which has a 20-year maximum.</p>\n<p>Four other former Pilgrim’s employees were charged separately and face trial next year.</p>\n<p>The case is U.S. v. Penn, 20-cr-00152, U.S. District Court, District of Colorado (Denver).</p>","source":"lsy1584095487587","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>KFC Wanted to ‘Beat Us Down,’ Pilgrim’s Pride Witness Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKFC Wanted to ‘Beat Us Down,’ Pilgrim’s Pride Witness Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-03 10:09 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/kfc-wanted-beat-us-down-202810293.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>KFC Corp.’s top price negotiator told executives for Pilgrim’s Pride Corp. in 2017 that “he was going to beat us down with a hammer and a baseball bat” as payback for three years of high chicken ...</p>\n\n<a href=\"https://finance.yahoo.com/news/kfc-wanted-beat-us-down-202810293.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"YUM":"百胜餐饮集团"},"source_url":"https://finance.yahoo.com/news/kfc-wanted-beat-us-down-202810293.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1186977790","content_text":"KFC Corp.’s top price negotiator told executives for Pilgrim’s Pride Corp. in 2017 that “he was going to beat us down with a hammer and a baseball bat” as payback for three years of high chicken prices. That’s according to the government’s star witness in the trial of 10 chicken-industry workers and executives charged with criminal price-fixing.\nRobert Bryant, a longtime Pilgrim’s Pride employee currently on leave, testified in Denver about talks between Pilgrim’s, the No. 2 U.S. chicken producer, and the company that manages supply for Yum! Brands Inc.’s KFC, Pizza Hut and Taco Bell fast-food restaurants. The KFC negotiator, Pete Suerken, was working on a new contract with Pilgrim’s after a three-year deal that included unprecedented price increases, according to Bryant, who took the stand Monday and Tuesday.\nAt the heart of the matter is whether the defendants conspired to inflate prices in the $95 billion U.S. market. During opening remarks last week, Justice Department lawyer Michael Koenig said the insiders, who worked for competing chicken companies including top producer Tyson Foods Inc., came together to create “massive, historic price increases” and stonewalled efforts by customers including KFC to negotiate them lower.\nThe defendants, who include former Pilgrim’s chief executives Jayson Penn and William Lovette, have all pleaded not guilty and are fighting the charges in the trial. They claim there was no conspiracy to fix prices or rig bids. Efforts to discover details of competitors’ prices were legal and chicken prices were the result of market forces, not illegal collusion, they said.\nBryant is taking the stand with immunity as a result of a Pilgrim’s plea deal, and his testimony has been hotly anticipated as key to the government’s case. On cross-examination, Bryant admitted that he had lied to the FBI “multiple times” on matters unrelated to the price-fixing investigation. The subject of Bryant’s lies wasn’t made public.\n‘Two-Way Street’\nBryant on Monday coolly pointed out for jurors the former colleagues and industry contacts who face charges that could land them in prison and bring million-dollar fines. He said Pilgrim’s and its competitors routinely shared information about pricing and planned bids “to increase prices or to limit a decrease, depending on the market conditions.”\n“My understanding is it was a two-way street,” Bryant told jurors. “We received their prices and they received ours.”\nHe testified that the goal in 2014 was to raise prices. In 2017, the aim was to limit the damage at a time when prices were declining. KFC that year forced Pilgrim’s Pride to reduce prices and decreased the company’s volume, in retaliation for the earlier contract.\n“He was upset about 2014,” Bryant said.\nProsecutors showed jurors Bryant’s handwritten notes from 2017 showing what he testified were planned bids by five Pilgrim’s competitors, including Tyson. Suppliers bid every year on contracts with the biggest fast-food companies, including KFC, Chick-fil-A Inc. and Popeyes Louisiana Kitchen Inc. The contracts help set the business prospects for the companies as well as the prices paid by people who eat chicken.\n‘Pandemic Profiteering’\nBryant conceded, under cross-examination by lawyer Michael Feldberg, that the numbers in his notes didn’t match the actual prices that were later charged by the companies. Feldberg pressed Bryant to acknowledge market influences on chicken prices, including severe shortages in 2014. And he suggested Bryant is lying about an agreement among the defendants to fix prices to curry favor with the government and avoid facing criminal charges himself.\nWhile the evidence covers alleged efforts to fix prices and rig bids from 2012 to early 2019, the findings could set the stage for further moves against the industry, which has caught the ire of the Biden administration. Officials have said meatpackers engaged in “pandemic profiteering,” squeezing consumers and farmers.\nGreeley, Colorado-based Pilgrim’s Pride, a unit of Brazilian food giant JBS SA, pleaded guilty to price-fixing conspiracy in February and was sentenced to pay $108 million in fines. As part of the plea deal, Pilgrim’s agreed to cooperate with the government investigation. In a statement last week, the company said it is “focused on maintaining our commitment to fair and honest competition in compliance with U.S. antitrust laws.”\nTyson last year said it was cooperating with the Justice Department.\n10 Defendants\nIn addition to Penn and Lovette, prosecutors charged Roger Austin, a former vice president of Pilgrim’s; Mikell Fries, president of Claxton Poultry Farms Inc.; Scott Brady, a Claxton vice president; Timothy Mulrenin, a Perdue Farms Inc. executive who previously worked at Tyson; William Kantola, a Koch Foods Inc. sales executive; Jimmie Lee Little, a former Pilgrim’s Pride sales director; Gary Brian Roberts, a Case Farms Inc. employee who had previously worked at Tyson; and Rickie Blake, a former director and manager at George’s Inc.\nAll are charged with violating the Sherman Act, a law that dates to 1890 and is intended to preserve competition in U.S. markets. Each defendant is charged with a single count of conspiracy to restrain trade, which carries a maximum of 10 years in prison. Little is also charged with obstruction of justice, which has a 20-year maximum.\nFour other former Pilgrim’s employees were charged separately and face trial next year.\nThe case is U.S. v. Penn, 20-cr-00152, U.S. District Court, District of Colorado (Denver).","news_type":1},"isVote":1,"tweetType":1,"viewCount":235,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":849836891,"gmtCreate":1635740774157,"gmtModify":1635740774157,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/849836891","repostId":"1164035523","repostType":4,"repost":{"id":"1164035523","pubTimestamp":1635736469,"share":"https://www.laohu8.com/m/news/1164035523?lang=&edition=full","pubTime":"2021-11-01 11:14","market":"us","language":"en","title":"2 Growth Stocks That Could Deliver 1,000% Returns","url":"https://stock-news.laohu8.com/highlight/detail?id=1164035523","media":"Motley Fool","summary":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders h","content":"<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist&nbsp;<b>Axsome Therapeutics</b>, the cancer specialist&nbsp;<b>Exelixis</b>, and the electric car pioneer&nbsp;<b>Tesla</b>&nbsp;have all delivered tenfold returns for investors who bought these names at their low points.</p>\n<p>Which stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist&nbsp;<b>Mereo BioPharma Group</b>(NASDAQ:MREO)and the diabetes-focused medical device company&nbsp;<b>Senseonics Holdings</b>(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced&nbsp;healthcare stocks&nbsp;have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.</p>\n<p>Here's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.</p>\n<p><b>Mereo BioPharma: A bet on the future of immunotherapy</b></p>\n<p>The London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.</p>\n<p>What's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the&nbsp;anti-TIGIT therapy&nbsp;known as etigilimab. Several major drug companies, such as&nbsp;<b>BeiGene</b>,<b>Bristol Myers Squibb</b>,<b>Merck</b>, and&nbsp;<b>Roche</b>, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.</p>\n<p>As things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.</p>\n<p>What's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.</p>\n<p><b>Senseonic: A rising tide lifts all boats</b></p>\n<p>Senseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10%&nbsp;<i>per year</i>&nbsp;over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.</p>\n<p>So far, Senseonics has only captured a&nbsp;small sliver&nbsp;of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company&nbsp;submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.</p>\n<p>Why does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from&nbsp;<b>DexCom</b>&nbsp;and&nbsp;<b>Abbott Laboratories</b>, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.</p>\n<p>What's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.</p>\n<p>All told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>2 Growth Stocks That Could Deliver 1,000% Returns</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n2 Growth Stocks That Could Deliver 1,000% Returns\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-01 11:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SENS":"Senseonics Holdings,Inc.","MREO":"Mereo Biopharma Group Plc"},"source_url":"https://www.fool.com/investing/2021/10/31/2-growth-stocks-that-could-deliver-1000-returns/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1164035523","content_text":"Thanks to the ongoing innovation revolutions in both the tech and healthcare sectors, shareholders have been enjoying historic returns on capital over the past decade. For example, the central nervous system disorder drug specialist Axsome Therapeutics, the cancer specialist Exelixis, and the electric car pioneer Tesla have all delivered tenfold returns for investors who bought these names at their low points.\nWhich stocks might be the next Axsome, Exelixis, or Tesla from a growth standpoint? The cancer/rare disease specialist Mereo BioPharma Group(NASDAQ:MREO)and the diabetes-focused medical device company Senseonics Holdings(NYSEMKT:SENS)could both be gearing up for a monstrous run higher soon. In fact, these two low-priced healthcare stocks have a decent shot at generating 1,000%-plus returns for their shareholders within the next two to three years.\nHere's a brief overview on the risks and potential rewards associated with each of these promising growth vehicles.\nMereo BioPharma: A bet on the future of immunotherapy\nThe London-based biopharma Mereo hasn't exactly set the world on fire since its American depository shares (ADS) made their debut on the Nasdaq stock exchange. Keeping with this theme, the biotech's ADSes have lost approximately 65% of their value since April 2019. This steady downward trend shouldn't scare away aggressive investors, however. Mereo's plunging share price, after all, is more about Mr. Market's well-known impatience with clinical-stage biotechs, rather than the company's underlying value proposition.\nWhat's the scoop? Mereo is a small-cap company with six assets under development for both cancer and rare diseases. However, the one drug candidate that could undoubtedly send the company's shares rocketing higher is the anti-TIGIT therapy known as etigilimab. Several major drug companies, such as BeiGene,Bristol Myers Squibb,Merck, and Roche, have anti-TIGIT therapies under development due to their potential to boost the efficacy and durability of cancer immunotherapy treatments in general. Mereo's etigilimab is currently in a combined phase 1/2 basket study to evaluate its utility as part of combination treament, along with Bristol's megablockbuster checkpoint inhibitor Opdivo, for a variety of solid tumors.\nAs things stand now, Mereo's anti-TIGIT candidate is slated to yield top-line data from this basket trial in approximately 18-months from now. During this lengthy interval, however, the drugmaker ought to provide multiple updates on etigilimab's progress, which could turn out to be a series of major catalysts for its share price in the coming months. Another bit of good news is that Mereo's cash runway reportedly extends into 2024. That's key, because it means that the biotech shouldn't have to repeatly tap the public markets for capital over the next year and a half.\nWhat's the downside risk? Mereo's management team has been open about its desire to partner with larger biopharmas. Etigilimab, for its part, could spark either a high dollar licensing agreement or a full-on buyout within the next two years. So a lot is riding on this single experimental drug. Unfortunately, early stage cancer therapies fail more often than not in the clinic. As a failure in this case would weigh heavily on the biotech's share price, potential investors may want to keep any initial position on the small side.\nSenseonic: A rising tide lifts all boats\nSenseonics' stock is worth a look by ultra-aggressive investors due to its implantable continuous glucose monitoring (CGM) device franchise known as Eversense. The lowdown is that the CGM market has been growing by over 10% per year over the past five years, according to a report by Grand View Research. What's more, this space is forecast to grow by at least 10% per year over the next five years. That's definitely a favorable trend for a small-cap CGM player like Senseonics.\nSo far, Senseonics has only captured a small sliver of this multi-billion dollar medical device market with its Eversense franchise. But the company is hoping to drastically improve its competitive positioning with a potential regulatory approval by the Food and Drug Administration (FDA) for its 180-day version of the Eversense CGM system. The medical device company submitteda regulatory application to the FDA for this proposed product over a year ago. So a decision could come any day now.\nWhy does this FDA approval matter? Senseonics' internal projections have the company's top-line rising at a compound annual growth rate of over 70% over the next five years as a result of this key regulatory nod. The long and short of it is that the current 90-day Eversense CGM system isn't particularly competitive in the U.S. against the market-leading devices from DexCom and Abbott Laboratories, respectively. But this longer-lasting version of the device could cause sales to skyrocket in the coming years.\nWhat's the risk? Senseonics is competing in a jam-packed space against a number of well-capitalized medical-device giants. So there is a chance that this long-awaited FDA approval won't spark a parabolic rise in sales. That's not a knock against Senseonics' CGM system, but rather the harsh reality of competing against healthcare companies with vastly superior resources. Investors shouldn't ignore this potential risk factor.\nAll told, Senseonics could be on the verge of a game-changing regulatory event that might prove to be a key inflection point for the company's CGM franchise. If true, this medical device company's stock should turn out to be a downright bargain at these levels.","news_type":1},"isVote":1,"tweetType":1,"viewCount":79,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874953784,"gmtCreate":1637722659359,"gmtModify":1637722659423,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874953784","repostId":"1178572049","repostType":4,"repost":{"id":"1178572049","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637721621,"share":"https://www.laohu8.com/m/news/1178572049?lang=&edition=full","pubTime":"2021-11-24 10:40","market":"us","language":"en","title":"Musk Has Now Sold More Than Half the Stock He Vowed on Twitter","url":"https://stock-news.laohu8.com/highlight/detail?id=1178572049","media":"Tiger Newspress","summary":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfwa","content":"<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Has Now Sold More Than Half the Stock He Vowed on Twitter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Has Now Sold More Than Half the Stock He Vowed on Twitter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-24 10:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178572049","content_text":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.\nThe billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.\nWith the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.\n\nTo reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.\nMusk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.\nMusk, 50, is the world’s richest person with a $303.7 billion fortune, according to the Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":487,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":847463409,"gmtCreate":1636546529729,"gmtModify":1636546529907,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay 👌&nbsp;","listText":"Okay 👌&nbsp;","text":"Okay 👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/847463409","repostId":"1153527139","repostType":4,"repost":{"id":"1153527139","pubTimestamp":1636545864,"share":"https://www.laohu8.com/m/news/1153527139?lang=&edition=full","pubTime":"2021-11-10 20:04","market":"us","language":"en","title":"Tesla Further Extends Delivery Time For Model Y Standard Range In China","url":"https://stock-news.laohu8.com/highlight/detail?id=1153527139","media":"Benzinga","summary":"Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in Chi","content":"<p><b>Tesla</b>&nbsp;<b>Inc’s</b>&nbsp;mid-size sports utility vehicle&nbsp;<b>ModelY</b>&nbsp;would now take even longer with deliveries in China, the electric vehicle maker’s website shows.</p>\n<p><b>What Happened:</b>The delivery time for the $43,200 Model Y standard range is now stretched to 10-14 weeks, from the earlier&nbsp;6-10 weeks range.</p>\n<p>The delivery for the Long Range and the Performance variant is estimated to take place in the fourth quarter; cnEVpost first&nbsp;reported&nbsp;on the development.</p>\n<p><b>Why It Matters:</b>Tesla launched the locally made Model Y standard range in July and started customer deliveries on August 26. The entry-level variant of Model Y uses CATL's more affordable lithium iron phosphate batteries.</p>\n<p>The&nbsp;<b>Elon</b>&nbsp;<b>Musk</b>-led company&nbsp;sold 54,391 electric vehicles&nbsp;to dealers in China in October, a rise of 348% on a year-on-year basis, as per China Passenger Car Association.</p>\n<p><b>Price Action:</b>Tesla shares closed 11.99% lower at $1,023.50 a share on Tuesday.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tesla Further Extends Delivery Time For Model Y Standard Range In China</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTesla Further Extends Delivery Time For Model Y Standard Range In China\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-10 20:04 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in China, the electric vehicle maker’s website shows.\nWhat Happened:The delivery time for the $43,200 ...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.benzinga.com/news/21/11/24005848/tesla-further-extends-delivery-time-for-model-y-standard-range-in-china","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1153527139","content_text":"Tesla Inc’s mid-size sports utility vehicle ModelY would now take even longer with deliveries in China, the electric vehicle maker’s website shows.\nWhat Happened:The delivery time for the $43,200 Model Y standard range is now stretched to 10-14 weeks, from the earlier 6-10 weeks range.\nThe delivery for the Long Range and the Performance variant is estimated to take place in the fourth quarter; cnEVpost first reported on the development.\nWhy It Matters:Tesla launched the locally made Model Y standard range in July and started customer deliveries on August 26. The entry-level variant of Model Y uses CATL's more affordable lithium iron phosphate batteries.\nThe Elon Musk-led company sold 54,391 electric vehicles to dealers in China in October, a rise of 348% on a year-on-year basis, as per China Passenger Car Association.\nPrice Action:Tesla shares closed 11.99% lower at $1,023.50 a share on Tuesday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":239,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":874925356,"gmtCreate":1637722096502,"gmtModify":1637722118342,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Good&nbsp;","listText":"Good&nbsp;","text":"Good","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/874925356","repostId":"1178572049","repostType":2,"repost":{"id":"1178572049","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1637721621,"share":"https://www.laohu8.com/m/news/1178572049?lang=&edition=full","pubTime":"2021-11-24 10:40","market":"us","language":"en","title":"Musk Has Now Sold More Than Half the Stock He Vowed on Twitter","url":"https://stock-news.laohu8.com/highlight/detail?id=1178572049","media":"Tiger Newspress","summary":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfwa","content":"<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Musk Has Now Sold More Than Half the Stock He Vowed on Twitter</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMusk Has Now Sold More Than Half the Stock He Vowed on Twitter\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2021-11-24 10:40</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.</p>\n<p>The billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.</p>\n<p>With the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.</p>\n<p><img src=\"https://static.tigerbbs.com/0578d57ebf3ae249460f3ec15770438d\" tg-width=\"954\" tg-height=\"337\" width=\"100%\" height=\"auto\"></p>\n<p>To reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.</p>\n<p>Musk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.</p>\n<p>Musk, 50, is the world’s richest person with a $303.7 billion fortune, according to the&nbsp;Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.</p>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1178572049","content_text":"After a few days’ break, Elon Musk resumed selling shares in Tesla Inc., now coming more than halfway to making good on his promise to offload 10% of his stake in the electric-car maker.\nThe billionaire sold an additional 934,091 shares for $1.05 billion, according to regulatory filings late on Tuesday U.S. time. He also exercised 2.15 million stock options, and the sales were made to cover the taxes related to that transaction, the documents showed.\nWith the most recent disposals, Musk now has offloaded 9.2 million shares and collected about $9.9 billion of proceeds since he conducted a Twitter poll asking whether he should sell 10% of his Tesla stake. A chunk of that money will go to taxes.\n\nTo reach the 10% threshold, Musk would need to sell some 17 million shares, or about 1.7% of the company’s outstanding stock. If his exercisable options are factored into his overall ownership, he’d need to sell even more.\nMusk has exercised millions of options since the Twitter poll, all of which were less than a year from their expiration date. In September, he established a pre-arranged trading plan to carry out “an orderly sale of shares related to the exercise of stock options,” filings show. The Nov. 6 Twitter poll didn’t disclose the existence of that plan.\nMusk, 50, is the world’s richest person with a $303.7 billion fortune, according to the Bloomberg Billionaires Index. He’s added $133.9 billion to his net worth this year, more than anyone else, amid a 57% jump in Tesla shares.","news_type":1},"isVote":1,"tweetType":1,"viewCount":276,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":840981654,"gmtCreate":1635575212312,"gmtModify":1635575212411,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Up Tesla&nbsp;","listText":"Up Tesla&nbsp;","text":"Up Tesla","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/840981654","repostId":"2179241322","repostType":4,"repost":{"id":"2179241322","pubTimestamp":1635561980,"share":"https://www.laohu8.com/m/news/2179241322?lang=&edition=full","pubTime":"2021-10-30 10:46","market":"us","language":"en","title":"Why Tesla Stock Jumped This Week","url":"https://stock-news.laohu8.com/highlight/detail?id=2179241322","media":"Motley Fool","summary":"Investors loved the electric-car maker's big third quarter and Hertz's move to order 100,000 Tesla vehicles.","content":"<h2>What happened</h2>\n<p>Shares of <b>Tesla</b> (NASDAQ:TSLA) surged higher this week, rising as much as 20.9%, according to data from S&amp;P Global Market Intelligence. As of this writing on Friday morning, the stock is up a total of 20% this week.</p>\n<p>The growth stock's gain was fueled by the continued momentum of its shares since the company reported strong third-quarter earnings earlier this month, a big order of Tesla vehicles from <b>Hertz</b>,&nbsp;and a number of analyst upgrades for the electric-car maker's stock.</p>\n<p><img src=\"https://g.foolcdn.com/image/?url=https%3A%2F%2Fg.foolcdn.com%2Feditorial%2Fimages%2F649348%2Fwhy-tesla-stock-is-rising.jpg&amp;w=700&amp;op=resize\" tg-width=\"700\" tg-height=\"393\" referrerpolicy=\"no-referrer\" width=\"100%\" height=\"auto\"></p>\n<p>Tesla's factory in California. Image source: The Motley Fool.</p>\n<h2>So what</h2>\n<p>Capturing the stock's momentum for the full month, Tesla shares are up more than 40% since the beginning of October. Much of this gain has come since the company reported third-quarter revenue and earnings per share that exceeded analyst expectations on Oct. 20.</p>\n<p>Adding to the stock's momentum, Hertz announced it would order 100,000 Tesla vehicles by the end of next year. A few days after this announcement, <b>Uber</b> said it would use 50,000 of those vehicles as rentals for its drivers beginning Monday.</p>\n<p>Analysts have been cheering the company's performance, with many of them increasing their 12-month price targets for the stock. Perhaps the most bullish call for Tesla shares came on Wednesday afternoon, when <b>Piper Sandler</b> analyst Alexander Potter said competition appears to be failing to curb Tesla's dominance. He gave shares a 12-month price target of $1,300.</p>\n<h2>Now what</h2>\n<p>This has been a huge year for Tesla as the company's revenue has soared and its operating margin has expanded significantly. Its third-quarter revenue increased 57% year over year, and operating margin was 14.6% -- up 534 basis points year over year. This helped net income increase 389% year over year to $1.6 billion.</p>\n<p>Looking ahead, Tesla is confident that its long-term profitability will improve further. \"We expect our operating margin will continue to grow over time,\" management explained in Tesla's third-quarter shareholder letter, \"continuing to reach industry-leading levels with capacity expansion and localization plans underway.\"</p>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Why Tesla Stock Jumped This Week</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nWhy Tesla Stock Jumped This Week\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-10-30 10:46 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2021/10/29/why-tesla-stock-jumped-this-week/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>What happened\nShares of Tesla (NASDAQ:TSLA) surged higher this week, rising as much as 20.9%, according to data from S&P Global Market Intelligence. As of this writing on Friday morning, the stock is ...</p>\n\n<a href=\"https://www.fool.com/investing/2021/10/29/why-tesla-stock-jumped-this-week/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.fool.com/investing/2021/10/29/why-tesla-stock-jumped-this-week/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2179241322","content_text":"What happened\nShares of Tesla (NASDAQ:TSLA) surged higher this week, rising as much as 20.9%, according to data from S&P Global Market Intelligence. As of this writing on Friday morning, the stock is up a total of 20% this week.\nThe growth stock's gain was fueled by the continued momentum of its shares since the company reported strong third-quarter earnings earlier this month, a big order of Tesla vehicles from Hertz, and a number of analyst upgrades for the electric-car maker's stock.\n\nTesla's factory in California. Image source: The Motley Fool.\nSo what\nCapturing the stock's momentum for the full month, Tesla shares are up more than 40% since the beginning of October. Much of this gain has come since the company reported third-quarter revenue and earnings per share that exceeded analyst expectations on Oct. 20.\nAdding to the stock's momentum, Hertz announced it would order 100,000 Tesla vehicles by the end of next year. A few days after this announcement, Uber said it would use 50,000 of those vehicles as rentals for its drivers beginning Monday.\nAnalysts have been cheering the company's performance, with many of them increasing their 12-month price targets for the stock. Perhaps the most bullish call for Tesla shares came on Wednesday afternoon, when Piper Sandler analyst Alexander Potter said competition appears to be failing to curb Tesla's dominance. He gave shares a 12-month price target of $1,300.\nNow what\nThis has been a huge year for Tesla as the company's revenue has soared and its operating margin has expanded significantly. Its third-quarter revenue increased 57% year over year, and operating margin was 14.6% -- up 534 basis points year over year. This helped net income increase 389% year over year to $1.6 billion.\nLooking ahead, Tesla is confident that its long-term profitability will improve further. \"We expect our operating margin will continue to grow over time,\" management explained in Tesla's third-quarter shareholder letter, \"continuing to reach industry-leading levels with capacity expansion and localization plans underway.\"","news_type":1},"isVote":1,"tweetType":1,"viewCount":357,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875223948,"gmtCreate":1637659536449,"gmtModify":1637659536541,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"👌&nbsp;","listText":"👌&nbsp;","text":"👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875223948","repostId":"1170981862","repostType":4,"isVote":1,"tweetType":1,"viewCount":291,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":875229796,"gmtCreate":1637659508214,"gmtModify":1637659508214,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay 👌&nbsp;","listText":"Okay 👌&nbsp;","text":"Okay 👌","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/875229796","repostId":"2185638587","repostType":4,"repost":{"id":"2185638587","weMediaInfo":{"introduction":"Stock Market Quotes, Business News, Financial News, Trading Ideas, and Stock Research by Professionals","home_visible":0,"media_name":"Benzinga","id":"1052270027","head_image":"https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa"},"pubTimestamp":1637659145,"share":"https://www.laohu8.com/m/news/2185638587?lang=&edition=full","pubTime":"2021-11-23 17:19","market":"us","language":"en","title":"5 Stocks To Watch For November 23, 2021","url":"https://stock-news.laohu8.com/highlight/detail?id=2185638587","media":"Benzinga","summary":"Some of the stocks that may grab investor focus today are:\n\tWall Street expects  Best Buy Co Inc  (NYSE: BBY) to report quarterly earnings at $1.91 per share on revenue of $11.56 billion before the opening bell. Best Buy shares rose 0.7% to $139.00 in after-hours trading.\n","content":"<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects <b> Best Buy Co Inc </b> (NYSE:BBY) to report quarterly earnings at $1.91 per share on revenue of $11.56 billion before the opening bell. Best Buy shares rose 0.7% to $139.00 in after-hours trading.</li>\n <li><b><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications Inc </b> (NASDAQ:ZM) reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. Zoom Video shares, however, dropped 6.8% to $225.80 in the after-hours trading session.</li>\n <li>Analysts are expecting <b> <a href=\"https://laohu8.com/S/DLTR\">Dollar Tree, Inc.</a> </b> (NASDAQ:DLTR) to have earned $0.96 per share on revenue of $6.41 billion in the recent quarter. The company will release earnings before the markets open. Dollar Tree shares fell 0.7% to $131.70 in after-hours trading.</li>\n</ul>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/URBN\">Urban Outfitters</a>, Inc.</b> (NASDAQ:URBN) posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter. Urban Outfitters shares tumbled 12.1% to $32.78 in the after-hours trading session.</li>\n <li>Analysts expect <b> HP Inc </b> (NYSE:HPQ) to post quarterly earnings at $0.88 per share on revenue of $15.40 billion after the closing bell. HP shares rose 0.2% to $32.00 in after-hours trading.</li>\n</ul>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>5 Stocks To Watch For November 23, 2021</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n5 Stocks To Watch For November 23, 2021\n</h2>\n\n<h4 class=\"meta\">\n\n\n<div class=\"head\" \">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/d08bf7808052c0ca9deb4e944cae32aa);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Benzinga </p>\n<p class=\"h-time\">2021-11-23 17:19</p>\n</div>\n\n</div>\n\n\n</h4>\n\n</header>\n<article>\n<p>Some of the stocks that may grab investor focus today are:</p>\n<ul>\n <li>Wall Street expects <b> Best Buy Co Inc </b> (NYSE:BBY) to report quarterly earnings at $1.91 per share on revenue of $11.56 billion before the opening bell. Best Buy shares rose 0.7% to $139.00 in after-hours trading.</li>\n <li><b><a href=\"https://laohu8.com/S/ZM\">Zoom</a> Video Communications Inc </b> (NASDAQ:ZM) reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. Zoom Video shares, however, dropped 6.8% to $225.80 in the after-hours trading session.</li>\n <li>Analysts are expecting <b> <a href=\"https://laohu8.com/S/DLTR\">Dollar Tree, Inc.</a> </b> (NASDAQ:DLTR) to have earned $0.96 per share on revenue of $6.41 billion in the recent quarter. The company will release earnings before the markets open. Dollar Tree shares fell 0.7% to $131.70 in after-hours trading.</li>\n</ul>\n<ul>\n <li><b><a href=\"https://laohu8.com/S/URBN\">Urban Outfitters</a>, Inc.</b> (NASDAQ:URBN) posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter. Urban Outfitters shares tumbled 12.1% to $32.78 in the after-hours trading session.</li>\n <li>Analysts expect <b> HP Inc </b> (NYSE:HPQ) to post quarterly earnings at $0.88 per share on revenue of $15.40 billion after the closing bell. HP shares rose 0.2% to $32.00 in after-hours trading.</li>\n</ul>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZM":"Zoom","BK4505":"高瓴资本持仓","BK4504":"桥水持仓","BBY":"百思买","BK4548":"巴美列捷福持仓","DLTR":"美元树公司","BK4170":"电脑硬件、储存设备及电脑周边","BK4528":"SaaS概念","BK4023":"应用软件","BK4554":"元宇宙及AR概念","BK4532":"文艺复兴科技持仓","BK4094":"服装零售","BK4567":"ESG概念","BK4533":"AQR资本管理(全球第二大对冲基金)","URBN":"都市服饰","BK4525":"远程办公概念","BK4114":"综合货品商店","BK4535":"淡马锡持仓","BK4076":"电脑与电子产品零售","BK4551":"寇图资本持仓"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2185638587","content_text":"Some of the stocks that may grab investor focus today are:\n\nWall Street expects  Best Buy Co Inc  (NYSE:BBY) to report quarterly earnings at $1.91 per share on revenue of $11.56 billion before the opening bell. Best Buy shares rose 0.7% to $139.00 in after-hours trading.\nZoom Video Communications Inc  (NASDAQ:ZM) reported better-than-expected results for its third quarter on Monday. The company reported its customers that contribute more than $100,000 in the trailing 12 months totaled 2,507, up 94% year-over-year. Zoom Video shares, however, dropped 6.8% to $225.80 in the after-hours trading session.\nAnalysts are expecting  Dollar Tree, Inc.  (NASDAQ:DLTR) to have earned $0.96 per share on revenue of $6.41 billion in the recent quarter. The company will release earnings before the markets open. Dollar Tree shares fell 0.7% to $131.70 in after-hours trading.\n\n\nUrban Outfitters, Inc. (NASDAQ:URBN) posted upbeat earnings and sales results for the third quarter. Its same-store sales climbed 14.6% year-over-year during the quarter. Urban Outfitters shares tumbled 12.1% to $32.78 in the after-hours trading session.\nAnalysts expect  HP Inc  (NYSE:HPQ) to post quarterly earnings at $0.88 per share on revenue of $15.40 billion after the closing bell. HP shares rose 0.2% to $32.00 in after-hours trading.","news_type":1},"isVote":1,"tweetType":1,"viewCount":577,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878532818,"gmtCreate":1637204855941,"gmtModify":1637204855941,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878532818","repostId":"1163438397","repostType":4,"repost":{"id":"1163438397","pubTimestamp":1637202293,"share":"https://www.laohu8.com/m/news/1163438397?lang=&edition=full","pubTime":"2021-11-18 10:24","market":"us","language":"en","title":"Bitcoin Needs to Drop 80% Before Marathon Loses Money on Mining","url":"https://stock-news.laohu8.com/highlight/detail?id=1163438397","media":"Bloomberg","summary":"(Bloomberg) -- Bitcoin has a long way to drop before mining the digital token becomes unprofitable f","content":"<p>(Bloomberg) -- Bitcoin has a long way to drop before mining the digital token becomes unprofitable for North America’s largest crypto mining company.</p>\n<p>After factoring in energy and hosting costs, the breakeven rate on Bitcoin for Marathon Digital Holdings Inc. is roughly $6,500, according to Fred Thiel, the Las Vegas-based company’s chief executive officer. Even with this week’s drop from an all-time high of $68,991 to around $60,000, the world’s largest cryptocurrency would need to plunge 80% before hitting the breakeven level.</p>\n<p>“It’s obviously a very profitable business,” Thiel said on Bloomberg’s “QuickTake Stock” streaming program. “We can ride this market for quite a long time. Bitcoin would have to drop obviously 80% before it starts getting to be a challenging situation for us, so we’re quite comfortable with where our costs are today.”</p>\n<p>The breakeven estimate serves as a reminder on how profitable Bitcoin mining can be for larger-scale companies and helps to explain the almost fivefold increase in Marathon’s share price this year.</p>\n<p>Daily miner revenue is hovering near record highs, according to data compiled by crypto derivatives provider FRNT Financial Inc. Marathon has among the lowest mining costs per coin, DA Davidson analyst Chris Brendler -- who has a buy rating on the shares -- told Bloomberg. Miners earn new Bitcoin by solving complex mathematical equations that secure the blockchain network while processing transactions.</p>\n<p>Marathon’s shares plunged about 33% this week after a quarterly filing showed that the company received a subpoena from the U.S. Securities and Exchange Commission related to a partnership for a Montana data facility. Thiel declined to comment further on the probe.</p>\n<p>The company is planning upgrades to operations, with 130,000 previously purchased machines expected to go live from now to mid-2022. At the end of the third quarter, Marathon raised their hash rate, or their computational power, to 2.7 exahashes per second and generated 1,252 self-mined coins -- a 91% jump from second-quarter production; it held roughly 7,053 Bitcoin by quarter-end.</p>\n<p>Marathon tapped the debt markets this week to sell convertible bonds -- an offering that was increased to $650 million. The proceeds will be used to upgrade mining equipment and potentially fund acquisitions, Thiel said.</p>\n<p>“Having cash on the balance sheet allows us to take advantage of opportunities to buy more miners, or we could potentially acquire miner companies, we could invest in technologies that could dramatically lower or improve the energy efficiency of our mining operations,” Thiel said. “We want to be agile, we want to have optionality.”</p>","source":"lsy1612507957220","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Bitcoin Needs to Drop 80% Before Marathon Loses Money on Mining</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBitcoin Needs to Drop 80% Before Marathon Loses Money on Mining\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 10:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://finance.yahoo.com/news/bitcoin-needs-drop-80-marathon-211542806.html><strong>Bloomberg</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>(Bloomberg) -- Bitcoin has a long way to drop before mining the digital token becomes unprofitable for North America’s largest crypto mining company.\nAfter factoring in energy and hosting costs, the ...</p>\n\n<a href=\"https://finance.yahoo.com/news/bitcoin-needs-drop-80-marathon-211542806.html\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"MARA":"Marathon Digital Holdings Inc"},"source_url":"https://finance.yahoo.com/news/bitcoin-needs-drop-80-marathon-211542806.html","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1163438397","content_text":"(Bloomberg) -- Bitcoin has a long way to drop before mining the digital token becomes unprofitable for North America’s largest crypto mining company.\nAfter factoring in energy and hosting costs, the breakeven rate on Bitcoin for Marathon Digital Holdings Inc. is roughly $6,500, according to Fred Thiel, the Las Vegas-based company’s chief executive officer. Even with this week’s drop from an all-time high of $68,991 to around $60,000, the world’s largest cryptocurrency would need to plunge 80% before hitting the breakeven level.\n“It’s obviously a very profitable business,” Thiel said on Bloomberg’s “QuickTake Stock” streaming program. “We can ride this market for quite a long time. Bitcoin would have to drop obviously 80% before it starts getting to be a challenging situation for us, so we’re quite comfortable with where our costs are today.”\nThe breakeven estimate serves as a reminder on how profitable Bitcoin mining can be for larger-scale companies and helps to explain the almost fivefold increase in Marathon’s share price this year.\nDaily miner revenue is hovering near record highs, according to data compiled by crypto derivatives provider FRNT Financial Inc. Marathon has among the lowest mining costs per coin, DA Davidson analyst Chris Brendler -- who has a buy rating on the shares -- told Bloomberg. Miners earn new Bitcoin by solving complex mathematical equations that secure the blockchain network while processing transactions.\nMarathon’s shares plunged about 33% this week after a quarterly filing showed that the company received a subpoena from the U.S. Securities and Exchange Commission related to a partnership for a Montana data facility. Thiel declined to comment further on the probe.\nThe company is planning upgrades to operations, with 130,000 previously purchased machines expected to go live from now to mid-2022. At the end of the third quarter, Marathon raised their hash rate, or their computational power, to 2.7 exahashes per second and generated 1,252 self-mined coins -- a 91% jump from second-quarter production; it held roughly 7,053 Bitcoin by quarter-end.\nMarathon tapped the debt markets this week to sell convertible bonds -- an offering that was increased to $650 million. The proceeds will be used to upgrade mining equipment and potentially fund acquisitions, Thiel said.\n“Having cash on the balance sheet allows us to take advantage of opportunities to buy more miners, or we could potentially acquire miner companies, we could invest in technologies that could dramatically lower or improve the energy efficiency of our mining operations,” Thiel said. “We want to be agile, we want to have optionality.”","news_type":1},"isVote":1,"tweetType":1,"viewCount":633,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":878536636,"gmtCreate":1637204700313,"gmtModify":1637204700313,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/878536636","repostId":"1155680084","repostType":4,"repost":{"id":"1155680084","pubTimestamp":1637201163,"share":"https://www.laohu8.com/m/news/1155680084?lang=&edition=full","pubTime":"2021-11-18 10:06","market":"us","language":"en","title":"Elon Musk has sold more Tesla shares than he needs to pay current tax bill ","url":"https://stock-news.laohu8.com/highlight/detail?id=1155680084","media":"Marketwatch","summary":"DETROIT — Elon Musk is selling more Tesla shares than he needs to pay current tax obligations, and e","content":"<p>DETROIT — Elon Musk is selling more Tesla shares than he needs to pay current tax obligations, and experts say he’s either converting part of his fortune from stock to cash, or he’s saving for bigger tax bills that will come due next year.</p>\n<p>As of early Wednesday, Musk had sold roughly 8.2 million shares in the electric car and solar panel maker in the past nine days, worth a total of just over $8.8 billion.</p>\n<p>Of those, Musk sold 2.8 million shares worth about $3 billion specifically to pay taxes on three tranches of stock options that he exercised this week, according to filings with the U.S. Securities and Exchange Commission. That means he has sold roughly $5 billion more in shares than he needs at present.</p>\n<p>Under a compensation plan from 2012, Musk has options to buy 26.4 million shares. The options expire next year, and the tax bill will come due. Wedbush analyst Daniel Ives estimates the bill to be $10 billion to $15 billion, depending on the stock price. Musk’s options so far allowed him to buy shares at $6.24 each, and the stock is selling for around $1,080.</p>\n<p>Erik Gordon, a University of Michigan business and law professor, questioned why Musk would sell that many shares now to pay obligations that come due next year. He said accruing for future tax liabilities makes sense only if Musk expects the stock price to drop.</p>\n<p>“If you think the stock is going to go up, or if you think the stock is going to stay the same, you wouldn’t be selling extra shares,” he said.</p>\n<p>On Nov. 6, Musk asked his 60 million Twitter followers if he should sell some of his Tesla TSLA, +3.25% stock. “Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my stock,” he wrote. According to Musk, 58% of those who responded said yes.</p>\n<p>Musk also conceded his wealth is tied up in stock, tweeting that he doesn’t get a cash salary or bonus from anywhere. “I have only stock, thus the only way for me to pay taxes personally is to sell stock,” he wrote.</p>\n<p>Musk started selling last Monday, and as of Wednesday, he had liquidated about 5% of his holdings. His federal tax obligations could be as high as 40% on proceeds from some of the sales, said Brad Badertscher, an accounting professor at the University of Notre Dame.</p>\n<p>Musk could have cut his tax bill on the options in half if he had exercised the options and waited a year to sell the shares, Badertscher said. That’s because with an immediate sale, the gain is taxed as ordinary income. In a year, Musk would pay the much lower capital gains rate, he said.</p>","source":"market_watch","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Elon Musk has sold more Tesla shares than he needs to pay current tax bill </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nElon Musk has sold more Tesla shares than he needs to pay current tax bill \n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-18 10:06 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.marketwatch.com/story/elon-musk-has-sold-more-tesla-shares-than-he-needs-to-pay-current-tax-bill-01637190117?mod=newsviewer_click><strong>Marketwatch</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DETROIT — Elon Musk is selling more Tesla shares than he needs to pay current tax obligations, and experts say he’s either converting part of his fortune from stock to cash, or he’s saving for bigger ...</p>\n\n<a href=\"https://www.marketwatch.com/story/elon-musk-has-sold-more-tesla-shares-than-he-needs-to-pay-current-tax-bill-01637190117?mod=newsviewer_click\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"TSLA":"特斯拉"},"source_url":"https://www.marketwatch.com/story/elon-musk-has-sold-more-tesla-shares-than-he-needs-to-pay-current-tax-bill-01637190117?mod=newsviewer_click","is_english":true,"share_image_url":"https://static.laohu8.com/599a65733b8245fcf7868668ef9ad712","article_id":"1155680084","content_text":"DETROIT — Elon Musk is selling more Tesla shares than he needs to pay current tax obligations, and experts say he’s either converting part of his fortune from stock to cash, or he’s saving for bigger tax bills that will come due next year.\nAs of early Wednesday, Musk had sold roughly 8.2 million shares in the electric car and solar panel maker in the past nine days, worth a total of just over $8.8 billion.\nOf those, Musk sold 2.8 million shares worth about $3 billion specifically to pay taxes on three tranches of stock options that he exercised this week, according to filings with the U.S. Securities and Exchange Commission. That means he has sold roughly $5 billion more in shares than he needs at present.\nUnder a compensation plan from 2012, Musk has options to buy 26.4 million shares. The options expire next year, and the tax bill will come due. Wedbush analyst Daniel Ives estimates the bill to be $10 billion to $15 billion, depending on the stock price. Musk’s options so far allowed him to buy shares at $6.24 each, and the stock is selling for around $1,080.\nErik Gordon, a University of Michigan business and law professor, questioned why Musk would sell that many shares now to pay obligations that come due next year. He said accruing for future tax liabilities makes sense only if Musk expects the stock price to drop.\n“If you think the stock is going to go up, or if you think the stock is going to stay the same, you wouldn’t be selling extra shares,” he said.\nOn Nov. 6, Musk asked his 60 million Twitter followers if he should sell some of his Tesla TSLA, +3.25% stock. “Much is made lately of unrealized gains being a means of tax avoidance, so I propose selling 10% of my stock,” he wrote. According to Musk, 58% of those who responded said yes.\nMusk also conceded his wealth is tied up in stock, tweeting that he doesn’t get a cash salary or bonus from anywhere. “I have only stock, thus the only way for me to pay taxes personally is to sell stock,” he wrote.\nMusk started selling last Monday, and as of Wednesday, he had liquidated about 5% of his holdings. His federal tax obligations could be as high as 40% on proceeds from some of the sales, said Brad Badertscher, an accounting professor at the University of Notre Dame.\nMusk could have cut his tax bill on the options in half if he had exercised the options and waited a year to sell the shares, Badertscher said. That’s because with an immediate sale, the gain is taxed as ordinary income. In a year, Musk would pay the much lower capital gains rate, he said.","news_type":1},"isVote":1,"tweetType":1,"viewCount":172,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":872777162,"gmtCreate":1637582785582,"gmtModify":1637582785582,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Okay&nbsp;","listText":"Okay&nbsp;","text":"Okay","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/872777162","repostId":"1156227996","repostType":4,"repost":{"id":"1156227996","pubTimestamp":1637574816,"share":"https://www.laohu8.com/m/news/1156227996?lang=&edition=full","pubTime":"2021-11-22 17:53","market":"us","language":"en","title":"Ford's 160,000 Reservations Number For F-150 Lightning Doesn't Include Fleet Orders","url":"https://stock-news.laohu8.com/highlight/detail?id=1156227996","media":"Benzinga","summary":"Ford Motor Co’s highly-anticipated electric truck F-150 Lightning has 160,000 bookings but those ord","content":"<p><b>Ford Motor Co’s</b>&nbsp;highly-anticipated electric truck&nbsp;<b>F-150 Lightning</b>&nbsp;has&nbsp;160,000 bookings but those orders don't include fleet buyers, the company&nbsp;told&nbsp;Electrek.</p>\n<p><b>What Happened:</b>The base model of the Ford’s F-150 Lightning is expected to draw more commercial and fleet customers than the more expensive variants.</p>\n<p>The revelation means that customers are likely looking at longer wait times than previously anticipated, Electrek noted.</p>\n<p>The electric version of Ford’s most profitable and popular pickup truck&nbsp;would will go on sale in May at a ticket price of $39,974 and up&nbsp;for the base model and a range of 230 miles for the standard range.</p>\n<p>For perspective, the F-150 alone contributed over 27% of Ford’s total production numbers of 201,353 units in the month of October, as per the company data.</p>\n<p>The Dearborn, Michigan-based automaker is aiming to ramp up production for the F-150 Lightning electric truck and build 15,000 F-150s next year after the truck's spring launch, 55,000 in 2023 and eventually reach the 80,000 mark in 2024.</p>\n<p><b>Why It Matters:</b>Ford is expecting the popularity of its most-sold and the most-profitable full size pickup truck F-150 to trickle down to its electric variant as well.</p>\n<p>Ford CEO&nbsp;<b>Jim Farley</b>&nbsp;last week said the automaker will double electric vehicle production to 600,000 units by 2023 due to higher demand and said it aims the automaker to become the biggest electric vehicle maker in the world.</p>\n<p>Farley&nbsp;in May this year told investors&nbsp;the automaker plans to electrify its most iconic models and reconfirmed the plans to launch a commercial self-driving business by 2022.</p>\n<p>F-150 Lightning will be Ford’s second fully electric model on sale after Mustang Mach-E.</p>\n<p><b>Price Action:</b>Ford stock closed 0.87% lower at $19.39 a share on Friday.</p>","source":"lsy1606299360108","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Ford's 160,000 Reservations Number For F-150 Lightning Doesn't Include Fleet Orders</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nFord's 160,000 Reservations Number For F-150 Lightning Doesn't Include Fleet Orders\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-11-22 17:53 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.benzinga.com/news/21/11/24214595/fords-160-000-reservations-number-for-f-150-lightning-doesnt-include-fleet-orders><strong>Benzinga</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Ford Motor Co’s highly-anticipated electric truck F-150 Lightning has 160,000 bookings but those orders don't include fleet buyers, the company told Electrek.\nWhat Happened:The base model of the Ford’...</p>\n\n<a href=\"https://www.benzinga.com/news/21/11/24214595/fords-160-000-reservations-number-for-f-150-lightning-doesnt-include-fleet-orders\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"F":"福特汽车"},"source_url":"https://www.benzinga.com/news/21/11/24214595/fords-160-000-reservations-number-for-f-150-lightning-doesnt-include-fleet-orders","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1156227996","content_text":"Ford Motor Co’s highly-anticipated electric truck F-150 Lightning has 160,000 bookings but those orders don't include fleet buyers, the company told Electrek.\nWhat Happened:The base model of the Ford’s F-150 Lightning is expected to draw more commercial and fleet customers than the more expensive variants.\nThe revelation means that customers are likely looking at longer wait times than previously anticipated, Electrek noted.\nThe electric version of Ford’s most profitable and popular pickup truck would will go on sale in May at a ticket price of $39,974 and up for the base model and a range of 230 miles for the standard range.\nFor perspective, the F-150 alone contributed over 27% of Ford’s total production numbers of 201,353 units in the month of October, as per the company data.\nThe Dearborn, Michigan-based automaker is aiming to ramp up production for the F-150 Lightning electric truck and build 15,000 F-150s next year after the truck's spring launch, 55,000 in 2023 and eventually reach the 80,000 mark in 2024.\nWhy It Matters:Ford is expecting the popularity of its most-sold and the most-profitable full size pickup truck F-150 to trickle down to its electric variant as well.\nFord CEO Jim Farley last week said the automaker will double electric vehicle production to 600,000 units by 2023 due to higher demand and said it aims the automaker to become the biggest electric vehicle maker in the world.\nFarley in May this year told investors the automaker plans to electrify its most iconic models and reconfirmed the plans to launch a commercial self-driving business by 2022.\nF-150 Lightning will be Ford’s second fully electric model on sale after Mustang Mach-E.\nPrice Action:Ford stock closed 0.87% lower at $19.39 a share on Friday.","news_type":1},"isVote":1,"tweetType":1,"viewCount":526,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},{"id":876204588,"gmtCreate":1637314320200,"gmtModify":1637314320356,"author":{"id":"4094912318336650","authorId":"4094912318336650","name":"Big Bull","avatar":"https://static.tigerbbs.com/a882f1e1fca8900b7ba0fae0ed568a02","crmLevel":3,"crmLevelSwitch":0},"themes":[],"htmlText":"Is time to fly up to the moon Ali!&nbsp;[看涨]&nbsp;","listText":"Is time to fly up to the moon Ali!&nbsp;[看涨]&nbsp;","text":"Is time to fly up to the moon Ali! [看涨]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876204588","repostId":"876205840","repostType":1,"repost":{"id":876205840,"gmtCreate":1637314097576,"gmtModify":1637378903861,"author":{"id":"212008496769156","authorId":"212008496769156","name":"捷克Jack","avatar":"https://static.tigerbbs.com/7cc48e563d37c21562541a2874ce20e4","crmLevel":3,"crmLevelSwitch":0},"themes":[],"title":"财报季专供：中概风险，从权利金里赚回来吧","htmlText":"今天的主角是<a target=\"_blank\" href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 财报后大跌11%，可能还要跌。 原因很简单： 收入不及预期 利润不及预期 指引还下调了 唯一还不错的是云业务的发展不错以及海外活跃用户的增长。但中国人往往喜欢“丑话说在前面”，当这一季表现得这么糟糕的时候，往往就有可能是为了以后在做铺垫，因此很多人也在考虑要不要抄底。 财报季我做了很多“财报前期权策略”，本质上还是在意财报这种公司事件带来的波动性。的确，很多人谈“波动色变”，但是我觉得，波动也同时给我们带啦机会。 对期权玩家来说，波动——Volatility是最重要的数据指标之一。简单地说，当波动率越大的时候，相同情况产生的权利金就越高，这样对期权的概念而 今天的策略很简单，naked&nbsp;sell&nbsp;put 可能很多朋友都用惯了这个策略，我想再强调一些概念。 首先，Long和Short，分别代表“多方”和“空方”，代表你是看涨还是看跌。 然后，Buy和Sell，分别代表“买”和“卖”的动作，代表你对标的产品的交易动作。 那么，有Buy操作的一定是“多方”，有Sell操作的一定是“空方”对吗？ 显然不是。 因为期权分为“看涨期权Call”和“看跌期权Put”—— 当我们“Buy&nbsp;Put”，也就买入看跌期权的时候，我们就是“Short空方”，和我们“Sell&nbsp;Call”也就是卖出看涨期权的时候一样，都是“Short空方”； 反之，当我们“Buy&nbsp;Call”买入看涨期权的时候，我们就是“Long多方”，和我们“Sell&amp;nb","listText":"今天的主角是<a target=\"_blank\" href=\"https://laohu8.com/S/BABA\">$阿里巴巴(BABA)$</a> <a target=\"_blank\" href=\"https://laohu8.com/S/09988\">$阿里巴巴-SW(09988)$</a> 财报后大跌11%，可能还要跌。 原因很简单： 收入不及预期 利润不及预期 指引还下调了 唯一还不错的是云业务的发展不错以及海外活跃用户的增长。但中国人往往喜欢“丑话说在前面”，当这一季表现得这么糟糕的时候，往往就有可能是为了以后在做铺垫，因此很多人也在考虑要不要抄底。 财报季我做了很多“财报前期权策略”，本质上还是在意财报这种公司事件带来的波动性。的确，很多人谈“波动色变”，但是我觉得，波动也同时给我们带啦机会。 对期权玩家来说，波动——Volatility是最重要的数据指标之一。简单地说，当波动率越大的时候，相同情况产生的权利金就越高，这样对期权的概念而 今天的策略很简单，naked&nbsp;sell&nbsp;put 可能很多朋友都用惯了这个策略，我想再强调一些概念。 首先，Long和Short，分别代表“多方”和“空方”，代表你是看涨还是看跌。 然后，Buy和Sell，分别代表“买”和“卖”的动作，代表你对标的产品的交易动作。 那么，有Buy操作的一定是“多方”，有Sell操作的一定是“空方”对吗？ 显然不是。 因为期权分为“看涨期权Call”和“看跌期权Put”—— 当我们“Buy&nbsp;Put”，也就买入看跌期权的时候，我们就是“Short空方”，和我们“Sell&nbsp;Call”也就是卖出看涨期权的时候一样，都是“Short空方”； 反之，当我们“Buy&nbsp;Call”买入看涨期权的时候，我们就是“Long多方”，和我们“Sell&amp;nb","text":"今天的主角是$阿里巴巴(BABA)$ $阿里巴巴-SW(09988)$ 财报后大跌11%，可能还要跌。 原因很简单： 收入不及预期 利润不及预期 指引还下调了 唯一还不错的是云业务的发展不错以及海外活跃用户的增长。但中国人往往喜欢“丑话说在前面”，当这一季表现得这么糟糕的时候，往往就有可能是为了以后在做铺垫，因此很多人也在考虑要不要抄底。 财报季我做了很多“财报前期权策略”，本质上还是在意财报这种公司事件带来的波动性。的确，很多人谈“波动色变”，但是我觉得，波动也同时给我们带啦机会。 对期权玩家来说，波动——Volatility是最重要的数据指标之一。简单地说，当波动率越大的时候，相同情况产生的权利金就越高，这样对期权的概念而 今天的策略很简单，naked sell put 可能很多朋友都用惯了这个策略，我想再强调一些概念。 首先，Long和Short，分别代表“多方”和“空方”，代表你是看涨还是看跌。 然后，Buy和Sell，分别代表“买”和“卖”的动作，代表你对标的产品的交易动作。 那么，有Buy操作的一定是“多方”，有Sell操作的一定是“空方”对吗？ 显然不是。 因为期权分为“看涨期权Call”和“看跌期权Put”—— 当我们“Buy Put”，也就买入看跌期权的时候，我们就是“Short空方”，和我们“Sell Call”也就是卖出看涨期权的时候一样，都是“Short空方”； 反之，当我们“Buy Call”买入看涨期权的时候，我们就是“Long多方”，和我们“Sell&nb","images":[],"top":1,"highlighted":2,"essential":2,"paper":2,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://laohu8.com/post/876205840","isVote":1,"tweetType":1,"viewCount":0,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0},"isVote":1,"tweetType":1,"viewCount":462,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"CN","totalScore":0}],"lives":[]}